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Cardiac rehabilitation (CR) is a secondary prevention program known to 
improve clinical outcomes and health-related quality of life in individuals with 
cardiovascular disease, yet participation and completion rates are suboptimal. 
Additionally, a CR model or models that is/are most efficient for all cohorts of 
participants has yet to be established. The purpose of this study was to compare 
models of care from four geographically close CR sites that span an international 
border through examination of program characteristics and database variables. 
Participants were also characterized and examined for potential predictors of 
program completion at one site.  The most impactful findings were: 1) sites may 
want to consider collecting a standardized data battery during programming and 
implementing participation incentives to enhance program completion; 2) the 
collection of point/date of referral, travel distance, and availability of exercise 
equipment at home and gym membership, may want to be considered by all sites; 
and 3) increasing age and higher education were associated with program 
completion. This research will provide a foundation for comparisons of the 
“granular” program and participant details across sites to maximize participant and 
program success. As such, the expertise from all sites can be leveraged to lead 
discussions that strategize next steps in developing an ideal CR model or models 
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1.1 Cardiovascular Disease 
Cardiovascular disease (CVD) is currently the leading cause of death 
worldwide, taking 17.9 million lives in 2016 alone.1 CVD encompasses a group of 
disorders that affect both the heart and blood vessels of the heart, brain, and 
limbs.1 The majority of CVD-related mortality, however, because of coronary artery 
disease (CAD), which is a worldwide epidemic accounting for over nine million 
deaths in 2016.2 
CAD occurs when blood vessels that lead to the heart are diseased, and it 
may also be referred to as: coronary heart disease, ischaemic heart disease, 
atherosclerotic heart disease, or simply atherosclerosis.1,2 The pathological 
process of CAD is atherosclerosis, which is the formation of fatty deposits or 
plaque in the blood vessels that then limits blood flow and causes blood clots.3  
 Within Canada, the total cost of CVDs in 2005 was approximately $20.9 
billion and is predicted to rise to $28.3 billion by 2020.4 CAD remains a major cause 
of death in Canada, falling second only to cancer, where approximately 1 in 12 (2.4 
million) Canadians equal to or over the age of 20 years lived with CAD in 2012-
2013.5 In the province of Ontario, statistics do not specifically address the 
prevalence of CAD, but more than 24,000 Ontarians died in 2012 from CVD.6  
 Across a national border to the United States, CVD remains the leading 
cause of death and it is estimated by 2035 that 45.1% of the adult population (>130 
million people) will be diagnosed with CVD, resulting in an annual $1.1 trillion total 




United States and heart disease, which includes CAD is ranked as the 
predominant cause of death in many states, including Michigan.7,8  
1.1.1 The Pathogenesis of Coronary Artery Disease 
The pathological process of CAD, involves atherosclerosis in the coronary 
arteries, leading to a myriad of serious, potentially fatal, consequences. 
Atherosclerosis affects the layers of the arteries by way of endothelium 
dysfunction, the invasion of lipids, pro-inflammatory responses, and the 
multiplication/movement of vascular cells.9 To understand the pathological 
process of atherosclerosis, it is essential to comprehend the structure of a human 
artery.  
The arteries in the human body are composed of three layers: the tunica 
intima (the inner most layer also known as the endothelium, which houses the 
endothelial cells), the tunica media (the middle layer), and the adventitia 
(representing the outermost layer).3  
In the absence of atherosclerosis and during vascular homeostasis, 
endothelial cells interact with the passing blood and keep it in a liquid state.3 A 
normal functioning endothelium controls blood clot formation and breakdown by 
releasing plasminogen activators and other antithrombotic agents.3 Further, during 
vascular homeostasis vasodilators (e.g., nitric oxide [NO]) and vasoconstrictors 
are released by the endothelium to maintain equilibrium of the vascular tone.10 
Vasodilators cause the blood vessels to widen, whereas vasoconstrictors cause 
the blood vessels to narrow.10,11 Thus, during homeostasis a healthy vascular tone 




biosynthesis can become impaired with oxidative stress (i.e., the production of pro-
atherogenic reactive oxygenated species [ROS]).9 The cells responsible for the 
maintenance of vascular tone by relaxing and contracting in response to NO are 
smooth muscle cells (SMCs), primarily found within the layer of the artery 
surrounding the endothelium, the tunica media.3 However, throughout the 
atherogenic process, the migration and multiplication of SMCs into the 
endothelium supports the formation of atherosclerotic plaque through a series of 
steps.3 
The pathogenesis of atherosclerosis, and the eventual formation of 
atherosclerotic plaque, begins when dysfunction or injury occurs to the 
endothelium from the presence of one or more risk factors.3,12 The most common 
site of injury involves sections of the arteries that are exposed to augmented shear 
stress and disturbed blood flow, such as curvatures and branch points.13 The 
immune system responds to these injuries, classifying atherosclerosis as an 
inflammatory disease.14 In more detail, pro-inflammatory signaling proteins (i.e., 
cytokines) are released after the initiation of an injury to the endothelium and 
increase its permeability.15 This allows for the movement of lipoprotein particles 
(i.e., particles that carry cholesterol in the blood), particularly low-density 
lipoproteins (LDL), into the sub-endothelium space (Figure 1, #1).3,12,16,17 LDL 
undergoes oxidation once in the sub-endothelium space and the oxidized LDL 
along with other sources of oxidative stress (i.e., the risk factors discussed in the 




Moreover, cytokines promote the expression of adhesion molecules on the 
endothelium as a response to the endothelium injury.15,16 This pro-inflammatory 
response attracts immune cells such as monocytes, encouraging the binding of 
the immune cells to the expressed adhesion molecules and then the movement of 
the immune cells into the sub-endothelium space (Figure 1, #3).3,15,16 
Once in the sub-endothelium space, the monocytes are converted to 
macrophages, which have scavenger receptors to attach to the oxidized LDL, and 
then the macrophages ingest the oxidized LDL (Figure 1, #4).3,16 After the 
macrophages consume the oxidized LDL, the macrophages become foam cells, 
which further enhance the pro-inflammatory response by releasing more cytokines 
(Figure 1, #5).3,16 Foam cells continue to manifest and multiply within the sub-
endothelium space and form the lipid-rich core of atherosclerotic lesions, 
commonly referred to as “plaque”.3,16 
The lipid-rich core of the plaque becomes surrounded by a fibrous capsule 
or cap.3,16 This fibrous structure begins its formation with the movement of SMCs 
from the tunica media into the sub-endothelium space, where SMC proliferation is 
continued (Figure 1, #6).3,16 The SMCs uptake oxidized LDL and release 
extracellular matrix molecules that eventually create the fibrous cap that surrounds 
the lipid-rich core of the plaque (Figure 1, #7).3,16 This fibrofatty lesion continues to 
become more fibrous, which may occur with endothelial cell and SMC death 




Figure 1: The Pathogenesis of Atherosclerosis 
The green and blue spheres represent cytokines. Modified from Zipes and colleagues.3  
 
As evident by the pathogenic process described above, atherosclerosis is 
progressive, with clinical symptoms appearing years after its onset when plaque 
formation in the arteries is substantial enough to reduce blood flow.3 Initially, the 
artery can compensate for the presence of plaque by remodeling the innermost 
layer of the endothelium.18 The two forms of remodeling are negative remodeling, 
described by a decrease in the diameter of the artery, and positive remodeling, 
which expands the diameter of the artery.18 Negative remodeling is associated with 
stable plaque, whereas unstable plaque is prominent with positive remodeling.18 
However, the diameter expansion with positive remodeling is eventually inefficient 
in preventing blood flow impairments and the unstable plaque associated with 
positive remodeling can produce a thrombus due to complications such as the 
plaque fissuring, rupturing or eroding.3,19 These disturbances to the plaque and the 




1.1.2 Risk Factors 
Modifiable risk factors for CVD, such as physical inactivity and poor diet 
have contributed to the increasing prevalence of atherosclerosis.3 Fortunately, 
lifestyle interventions (e.g., increasing physical activity) when paired with cessation 
of smoking, can reduce the chance of experiencing a secondary vascular event by 
approximately 75%.1 
The modifiable risk factors for CVD that are influenced by lifestyle 
interventions include hypertension (high blood pressure), hyperlipidemia (high 
blood cholesterol), diabetes, poor diet, obesity, the use of tobacco, psychological 
factors (depression, anxiety, and stress), social factors, and physical 
inactivity.1,17,20,21 Unfortunately, some risk factors for CVD are non-modifiable, 
including sex, increasing age, ethnicity, and genetics/family history.21,22  
1.1.3 Modifiable Risk Factors  
The leading modifiable risk factor for CVD is hypertension with 24.1% of 
men and 20.1% of women over the age of 18 years diagnosed globally in 2015.1 
CAD is a CVD, where the increased pressure on the blood vessels that coincides 
with hypertension injures the endothelium and thus makes it more susceptible to 
the pathogenesis of atherosclerosis.23 Injury to the endothelium also occurs from 
the activation of many cellular signaling pathways that correspond with the 
pathogenesis of hypertension, leading to the production of ROS and therefore 
oxidative stress, which stimulates the inflammatory response associated with 
atherosclerosis.23 Additionally, the bioavailability of NO is reduced from the 




impaired.9,23 However, hypertension and its impact on CAD can be minimized with 
various lifestyle interventions such as dietary changes (e.g., adherence to the 
Dietary Approaches to Stop Hypertension or the Mediterranean diet, reduced 
alcohol consumption, reduced sodium intake), body weight management, smoking 
cessation, stress management, and increased physical activity.24,25  
Undoubtedly, the pathogenesis of atherosclerosis occurs in the presence of 
elevated blood cholesterol levels, thus the modifiable CVD risk factor of 
hyperlipidemia, particularly elevated LDL, is imperative to the development of 
CAD.3,26 LDL is present for the entire process of plaque development; from sub-
endothelium invasion to the formation of the lipid-rich core of the plaque.3,16 
Pharmacotherapy (e.g., statins) is commonly recommended in guidelines for 
controlling blood cholesterol levels, but smoking cessation, increased physical 
activity, body weight management, and a healthy diet provide favorable blood 
cholesterol changes as   
well.27–29   
Diabetes is also a modifiable risk factor for CVD, but the pathophysiology 
between diabetes and atherosclerosis warrants further investigation.9,30 However, 
it is understood that hyperglycemia is correlated with oxidative stress (i.e., ROS) 
leading to endothelium dysfunction.9,30 It is known that oxidative stress and the 
affiliated ROS increase the appearance of cytokines and begin the cascade of 
events that leads to the formation of atherosclerotic plaque.3 The detriments of 




diet while monitoring the intake of carbohydrates), body weight management, 
smoking cessation, physical activity, and psychosocial management.31  
 A poor diet is a modifiable CVD risk factor that can significantly impact the 
development of atherosclerosis. More specifically, to control the pathogenesis of 
atherosclerosis by lowering blood cholesterol levels (e.g., LDL levels) a limited 
dietary consumption of trans fats, saturated fats, and cholesterol is endorsed.27,28 
It is also suggested that individuals adopt a Mediterranean or similar diet to reduce 
the risk of CVD and related events.27,28 The Mediterranean diet incorporates whole 
grains, legumes, fresh vegetables, fruits, nuts, seeds, extra-virgin olive oil, 
moderate quantities of fish, low amounts of dairy products, and very low amounts 
of red meat, thus a diet opposite to this would be considered unfavourable or a 
poor diet for the prevention of CAD.32 Preliminary research demonstrates that 
adherence to the Mediterranean diet lowers blood cholesterol levels (i.e., LDL), 
decreases oxidative stress while supplying antioxidants, decreases inflammation, 
and increases immune function, all representing protective mechanisms against 
the development and progression of atherosclerosis.32  
Another modifiable risk factor for CVD is obesity. Obesity is accompanied 
by an unfavourable amount of adipose tissue, which is recognized as an endocrine 
organ that plays a role in the regulation of the endothelium.33 In detail, a high 
amount of adipose tissue contributes to the inflammatory response with the release 
of pro-inflammatory factors (e.g., cytokines) and the invasion of macrophages, 
which both stimulate the pathogenesis of atherosclerosis.33,34 Additionally, pro-and 




and can lead to endothelium dysfunction and vascular remodeling.33 Overall, 
adipose tissue stimulates an inflammatory response that contributes to the process 
of atherosclerosis.34 Fortunately, obesity can be modified, alleviating the effects on 
atherosclerosis, with a healthy weight loss program that incorporates a reduced 
caloric intake and healthy diet (e.g., the Mediterranean diet).35 Increased physical 
activity is also paramount, and other lifestyle interventions (e.g., education, goal-
setting, psychological counselling) delivered by a multidisciplinary team that 
encourage both diet and physical activity changes.35  
Tobacco use (i.e., cigarette smoking) is a modifiable CVD risk factor that 
contributes to atherosclerosis during the full duration of its pathogenesis, starting 
with injury to the endothelium from the oxidative stress (i.e., the presence of ROS) 
caused by cigarette smoke.36 The ROS from the presence of cigarette smoke also 
cause the oxidation of LDL, and it has been established that cigarette smoking 
increases the concentration of LDL in the blood.36,37 Overall, the release of 
inflammatory cytokines is amplified with cigarette smoking promoting the 
recruitment of immune cells (e.g., monocytes), and adhesion molecule expression 
is intensified, which together allows monocytes to bind and move into the sub-
endothelium space, eventually creating foam cells.3,9,15,16,36 Reduced NO formation 
is also associated with cigarette smoking, and thus vasodilation is impaired and 
therefore overall vascular homeostasis.9,36 However, with smoking cessation 
endothelium dysfunction can be reversed and endothelium function restored, as 
seen by the improvement in the vasodilation capabilities of the arteries within only 




cessation (i.e., tobacco cessation) guidelines that individuals should be provided 
guidance on how to quit smoking and support through behavioural and 
pharmacological treatment.39 
Furthermore, psychological factors such as depression, anxiety, and stress, 
and various social factors (e.g., social isolation or absence of social support and 
integration) are classified as modifiable risk factors for CVD.40,41 Research 
examining psychological concerns and CVD is still preliminary with the majority of 
studies focusing on depression, suggesting that the presence of depression 
increases the inflammatory response.40,42 Similar to depression, anxiety and stress 
are also proposed to increase the inflammatory response.40,42 A prevalence of 
social factors such as social isolation has also been shown to increase levels of 
inflammation, whereas social support and integration decrease levels of 
inflammation.43,44 Since atherosclerosis is an inflammatory disease, the activation 
of the inflammatory response by various psychological and social factors only 
propagate the entire process of plaque formation.14 Suggestions to modify 
psychological factors and social factors include increased social support, with 
concomitant education on how to manage these factors and establish self-help 
strategies.17 Individual or group counselling is beneficial as well to discuss how to 
implement lifestyle interventions to manage stress, and improve diet, tobacco use, 
and physical activity habits, as psychological factors are interrelated with these 
previously mentioned modifiable CVD risk factors.17,40 Moreover, referral to a 
mental health specialist may be beneficial for further treatment (e.g., 




Lastly, the modifiable CVD risk factor of physical inactivity contributes to the 
prevalence and severity of many other modifiable CVD risk factors (as mentioned 
previously) and to the development of atherosclerosis.45 In regard to the 
pathogenesis of atherosclerosis, the lack of shear stress associated with physical 
inactivity leads to endothelium dysfunction commencing the atherosclerosis 
process.3,45 Moreover, physical inactivity also results in unfavourable levels of 
cholesterol in the blood with increased LDL levels contributing to the development 
of plaque.3,17,45 Fortunately, the consequences of physical inactivity can be 
combatted by simply increasing physical activity levels.45 Shear stress in the 
vasculature is increased during bouts of physical activity, stretching the artery 
walls, which promotes the health of endothelial cells.45 Additionally, chronic 
physical activity positively alters blood lipid levels (e.g., a reduction in LDL levels).45 
Chronic physical activity also increases the availability of NO, which promotes 
vascular homeostasis as an essential vasodilator.9,46 Additionally, a decrease in 
oxidative stress is associated with physical activity by reducing the prevalence of 
ROS, even in individuals with CVD, thus diminishing the pro-inflammatory 
response by mitigating the release of cytokines and consequently the exposure of 
adhesion molecules.46,47 Evidently, physical activity can prevent the occurrence 
and progression of atherosclerosis and positivity impact the effect of other 
modifiable CVD risk factors as well.  
1.1.4 Non-modifiable Risk Factors  
As mentioned, not all risk factors for CVD are modifiable. For instance, sex 




States, CAD is more prevalent in men and appears 10 years earlier than it does in 
women.5,7 However, as age increases, the difference in prevalence of CAD 
between the sexes narrows, perhaps due to women losing the protective effect of 
estrogen after menopause.5 Estrogen is thought to protect women by lowering LDL 
levels and SMC multiplication and movement, while promoting vasodilation and 
beneficial endothelial cell multiplication and movement.48 
 Likewise, age is a non-modifiable CVD risk factor.21,22 The natural process 
of aging is associated with stiffening of the arteries and endothelium dysfunction.49 
As blood vessels age, production of NO is reduced and movement of SMCs into 
the sub-endothelium space is common.49 Therefore, when an individual’s age 
increases the individual becomes more susceptible to CVD, however by altering 
the formerly mentioned modifiable risk factors the influence of aging can be 
minimized.50 
Within Canada and the United States, there exists discrepancies in the 
prevalence of CVD risk factors across different ethnicities.51 This emphasizes the 
significance of ethnicity as a non-modifiable CVD risk factor.21,22 For example, 
hypertension is more common in Blacks compared to Whites, and diabetes is more 
common in Hispanics compared to Whites.51 Diabetes is also more common in 
Indigenous peoples compared to Whites, as is abdominal obesity and smoking.51 
Compared to Whites, differences have been observed between Arab, Chinese and 
Filipino individuals, but the research is limited (compared to that conducted with 




Overall, the occurrence of risk factors for CVD events varies amongst ethnicities, 
however the reasoning for this requires future investigation.51 
Family history increases both the risk and severity of CAD and therefore the 
chance of experiencing an MI.52,53 A study by Pandey and colleagues54 defined 
premature family history as the occurrence of an MI (e.g., fatal or non-fatal) or a 
clinical intervention (e.g., percutaneous coronary intervention [PCI], and/or 
coronary artery bypass grafting [CABG]) before 55 years of age in first-degree 
relatives who are men, and before 65 years of age in first-degree relatives who are 
women. This multi-ethnic study concluded that the incidence and progression of 
CAD is correlated with family history, especially if parents and siblings both have 
premature CAD.54  
1.1.5 Health Complications Associated with Coronary Artery Disease  
Many health complications can emerge with CAD and the associated 
presence of atherosclerosis. When a thrombus impedes blood flow in a coronary 
artery, inadequate amounts of oxygen are delivered to the cardiomyocytes – the 
subsequent impairment of blood flow of which is termed myocardial ischemia.3 In 
many but not all individuals, a temporary symptom of myocardial ischemia is 
angina pectoris, which is pain or discomfort in the chest and adjacent areas (e.g., 
neck, jaw, arms and the abdomen).3 However, the exact location, severity, and 
duration of angina pectoris can vary drastically between individuals, particularly in 
women.3,55,56 Typical or stable angina pectoris is usually stimulated by over 
exertion and is relieved quickly by rest and short-acting nitroglycerin.3 Dissimilarly, 




while sleeping, and relief from rest and nitroglycerin is delayed.3 In approximately 
one third of individuals treated for ischemia, no symptoms are present, and this is 
known as silent (asymptomatic) ischemia and therefore lacks warning signs of the 
condition.3  
Furthermore, when a thrombus impedes the blood flow in a coronary artery 
and myocardial ischemia is not reversed or blood flow restored, an MI can develop 
and if long or severe enough, can cause cardiomyocyte death.3,57 The most recent 
universal definition of MI incorporates five types: spontaneous MI, MI secondary 
to an ischaemic imbalance, cardiac death due to MI, MI associated with a PCI, and 
MI associated with CABG.57 Spontaneous MI would be the appropriate 
classification if an individual had CAD, formed a thrombus, and suffered an MI.57 
In contrast, the classification of MI secondary to an ischemic imbalance is used 
when CAD is not the cause of a thrombus and restricted blood flow, and some 
other condition causes the blood flow impairment, such as a coronary artery 
vasospasm.57  
In addition to the five types of MI, an individual can be diagnosed with acute 
coronary syndrome (ACS) when the individual initially presents with symptoms of 
an MI or if the severity of the individual’s symptoms worsens.3 Myocardial ischemia 
can result in stable angina pectoris, but it can also cause ACS, which is subdivided 
into unstable angina pectoris, non-ST-segment elevation MI (NSTEMI), and ST-
segment elevation MI (STEMI).3 The characteristics of the thrombus differ for the 
classifications of ACS, where unstable angina pectoris and NSTEMI usually 




thrombus is usually present with STEMI.9 This relates to the severity of the 
diagnosis: STEMI correlates with cardiomyocyte death from an occlusive 
thrombus; acute occlusion or incomplete occlusion correlates with NSTEMI;  and 
even less severe occlusion correlates with unstable angina pectoris.9 
While NSTEMI and STEMI both present with clinical symptoms and cardiac 
biomarker changes (i.e., increase in cardiac troponin in the blood) that are 
suggestive of a cardiomyocyte/myocardium death, a 12-lead electrocardiogram 
(ECG) can be used to determine if the ST segment of the cardiac cycle is 
elevated.3 This is how the distinction between NSTEMI and STEMI is made; 
NSTEMI is not typically associated with  an elevated ST segment, whereas STEMI 
is associated with an elevated ST segment .3 Furthermore, clinical symptoms can 
also be the same for unstable angina pectoris, however a normal ECG may (i.e., 
no changes in the ST segment) exist and there is no elevation of cardiac 
biomarkers (i.e., cardiac troponin) indicating myocardium death.3 
Alternatively, a health complication that manifests with end-stage CAD (with 
or without the occurrence of an MI) is heart failure accompanied by left ventricular 
systolic dysfunction.9 The progressive disorder of heart failure originates when 
damage to the myocardium is induced.3,9 Tissue damage experienced from 
myocardial ischemia reduces the heart’s contractibility, therefore the heart tries to 
adapt by modifying the left ventricle (e.g., left ventricle hypertrophy) to maintain 
pumping capacity and systolic function, but there is ultimately impaired ventricle 
filling and emptying.3,9,58 Notably, the presence of diastolic dysfunction coexists to 




adaptations (e.g., blood volume, vascular, neurohormonal) in an attempt to 
maintain cardiac output, however these compensations are not entirely efficient 
and over time the disease progresses.9 
Moreover, heart failure can be classified in terms of ejection fraction. Firstly, 
there is heart failure with a preserved ejection fraction (HFpEF), where the left 
ventricle can eject 50% or more of the blood it is supplied.3 Secondly, there is heart 
failure with a reduced ejection fraction (HFrEF), where the left ventricle ejects less 
than 40% of the blood it is supplied.3 Notably, heart failure with a mid-range 
ejection fraction (HFmrEF) is where the left ventricle can eject 40-50% of the blood 
it is supplied.3 It is important to note that CAD (i.e., impaired blood flow or an MI) 
is the primary cause of heart failure in industrialized countries.3 Moreover, CAD 
accounts for more HFrEF than HFpEF cases, whereas HFpEF often results from 
systolic hypertension.59,60 
Previously, acute heart failure was thought to be part of the progression of 
heart failure, but it is now recognized as its own disorder.3 Generally, the diagnosis 
of acute heart failure is applied when an individual requires immediate medical 
attention due to the exacerbation of heart failure symptoms, whether the symptoms 
are reoccurring or appearing for the first time.3 Despite the presence of the word 
“acute”, the exacerbation of the symptoms may happen over time, and eventually 
may be amplified enough to require medical attention.3 
The myocardial ischemia and cardiomyocyte death experienced with MI can 
cause electrophysiological changes within the heart.61 Consequently, cardiac 




irregular, negatively affecting the heart rate and cardiac output and potentially 
causing cardiac arrest if the electrical activity is not normalized.62 If an arrhythmia 
causes the heart rate to be too slow, it is termed a bradyarrhythmia, whereas a 
heart rate that is too fast is labeled as tachyarrhythmia.9 Arrhythmias, especially 
those related to the ventricles, are frequently associated with the myocardial 
ischemia experienced with CAD, and MI.9 Ischemic tissue and the production of 
scar tissue after  MI can block electrical propagation in the heart causing the 
electrical impulse to reroute itself around the barrier (i.e., the ischemic tissue and 
scar tissue), which is known as re-entry and is most often associated with 
tachyarrthymias.9 Ventricular arrhythmias such as ventricular tachycardia are 
common after an MI and can progress into ventricular fibrillation, and potentially 
sudden cardiac death.9 Arrhythmias known as “heart blocks” can result from 
ischemic cardiomyocyte damage as well and involve the atrioventricular electrical 
propagation being impaired.9 
 Sudden cardiac death is the most severe consequence of an MI, heart 
failure or a cardiac arrhythmia.3 Sudden cardiac death (i.e., cardiac arrest) has 
been defined by Zipes and colleagues3 as “natural death from cardiac causes 
heralded by abrupt loss of consciousness within one hour of the onset of an acute 
change in cardiovascular status”. Overall, the cause of death is related to cardiac 
dysfunction, is unexpected, rapid, and considered natural.3 
1.1.6 Surgical Interventions Associated with Coronary Artery Disease   
Surgical interventions are often required for CAD. If an individual suffers 




presence of plaque in the arteries to relieve symptoms and improve the probability 
of survival.3,63 The coronary arteries are accessed by inserting a catheter through 
the femoral, brachial, or radial artery.3 Once the catheter has reached the affected 
coronary artery, different methods are used to expand (e.g., balloon angioplasty) 
or support via stents (e.g., bare-metal or drug-eluting) the coronary lumen or to 
remove the plaque (e.g., coronary atherectomy).3,63 
Depending on the complexity of the diagnosis, CABG (please refer to 
section 1.1.4) may be the more appropriate revascularization procedure.20 The 
gold standard for CABG is to induce cardiac arrest in the individual, then conduct 
an on-pump CABG to control hemodynamics while operating.64 On-pump CABG 
involves cross-clamping the aorta and bypassing the cardiopulmonary system to 
control hemodynamics.65 Alternatively, CABG can be performed on a beating 
heart, which is known as off-pump CABG and uses tactics to minimize cardiac 
motion.64 A median sternotomy is the most efficient incision technique to access 
the heart; however, other methods have evolved such as the less invasive 
endoscopic method with robot assistance.64 As the name implies, new routes for 
arteries or veins are grafted to bypass the affected coronary arteries and improve 
blood flow.64 CABG is recommended to improve survival when there is greater 
than or equal to 50% stenosis in the left main coronary artery however, there are 
exceptions for when PCI may be preferred.63,64 CABG is also recommended to 
improve survival when greater than or equal to 70% stenosis occurs in three major 
coronary arteries, or when it occurs in one major coronary artery plus the proximal 




When there is greater than or equal to 70% stenosis, PCI or CABG can 
improve survival for individuals with sudden cardiac arrest who are suffering from 
ventricular tachycardia due to myocardial ischemia.63,64 Additionally, when an 
individual is expected to positively respond to revascularization, and if other 
medical interventions have not relieved unacceptable levels of angina, PCI or 
CABG can be performed when 1 or more coronary arteries have greater than or 
equal to 70% stenosis to improve symptoms.63,64 PCI or CABG can also be 
performed to treat ACS.63,64,66 In individuals with unstable angina pectoris and 
NSTEMI, the purpose is to relieve symptoms, reduce the occurrence of an MI, and 
prevent death.63,64,66 Moreover, in individuals with STEMI, PCI and CABG can also 
be performed to reduce complications and death.63,64,66 Overall, the choice 
between PCI and CABG to treat CAD and its complications is specific to the 
individual with many factors to be considered.63,64,66 
If the issue concerns the electrical function of the heart, an implantable 
electronic device can be inserted subcutaneously below the clavicle.12 To maintain 
atrioventricular synchrony, a permanent pacemaker is implanted with leads placed 
in the right atrium and right and/or left ventricle to sense and restore electrical 
activity.12 Comparatively, an implantable cardioverter- defibrillator has leads that 
innervate the heart transvenously to detect fatal ventricular tachyarrhythmias and 
regain proper pacing, or provide defibrillation if necessary.12 
Ultimately, in instances where surgical interventions do not relieve 
symptoms and end-stage heart failure is present, an orthotopic heart transplant 




1.1.7 Pharmacotherapy Associated with Coronary Artery Disease   
 The administration of cardioprotective medications can be effective in 
preventing and treating CAD as well.20 Beta blockers are a class of drugs that lower 
heart rate and blood pressure levels to help treat CAD.20 Angiotensin-converting 
enzyme inhibitors and angiotensin-receptor blockers are other classes of drugs 
prescribed for CAD to dilate the arteries.20 By dilating the arteries, angiotensin-
converting enzyme inhibitors and angiotensin-receptor blockers lower systemic 
blood pressure and the pressure in the heart, preventing the heart from 
overworking.20 Consequently, the heart can recover from an MI, there is a 
decreased risk for arrhythmias, and cardiac dysfunction due to heart failure is 
improved.20 Additionally, the class of drugs known as platelet inhibitors limit platelet 
aggregation and decrease inflammation, therefore this class of drugs may be 
prescribed for CAD treatment.20 Since this class of drugs prevents the formation 
of a thrombus, they are usually prescribed after a PCI to prevent a thrombus from 
forming in a stent.20 Another vital class of drugs for prevention and treatment of 
CAD are statins, which lower blood cholesterol levels, decrease inflammation, and 
promote the thickening of the fibrous cap; all important approaches to preventing 
plaque disturbance and its resulting consequences.20   
1.1.8 Lifestyle Interventions for Coronary Artery Disease 
 While surgical interventions and pharmacotherapies are prevalent in 
cardiology, it has been apparent for many years that the field should be integrative 
by emphasizing disease prevention and lifestyle interventions to improve medical 




describe this ideology of care and are greatly shaped by the CVD risk factors 
established by the Framingham Heart Study.3,67 Essentially, the main objective of 
integrative cardiology is the prevention of disease, where the care provided models 
guidelines, but individuals also possess control to develop goals and therapeutic 
plans in synergy with healthcare providers.3 Integrative cardiology exceeds 
traditional standards of care in cardiology by emphasizing therapeutic plans that 
incorporate lifestyle interventions to yield the greatest outcomes for individuals by 
reducing the burden of CVD risk factors.3  
 Cardiac rehabilitation (CR) is an ideal example of integrative cardiology.68 
CR is a secondary prevention strategy delivered by a multidisciplinary team of 
health professionals, with a focus on lifestyle interventions (e.g., tobacco 
cessation, exercise training, and nutritional counselling) to manage the modifiable 
risk factors associated with CVD and ultimately CAD.69 CR aims to improve the 
overall well-being of participants, including physical, psychosocial, and vocational 
success.17,22 
1.2 Cardiac Rehabilitation  
1.2.1 Benefits of Cardiac Rehabilitation  
A recent Cochrane Systematic Review and meta-analysis (63 randomised 
controlled trials; 14,486 participants) provided evidence that exercise-based CR 
(primarily aerobic training; median intervention length of six months), compared to 
usual care (standard medical care with no form of exercise prescription and 
guidance), reduced cardiovascular mortality and the overall risk of hospital 




cause mortality.68 Due to the variance in health-related quality of life (HRQoL) 
measures, a meta-analysis was not conducted on this parameter, but in those 
studies including HRQoL there was evidence of improvement following exercise-
based CR participation.68  
It is important to note that the trials included exercise-only interventions and 
interventions employing more comprehensive secondary prevention strategies 
(i.e., exercise, educational, and psychosocial components).68 The level of 
supervision varied (i.e., unsupervised or supervised) as did the location of the 
interventions (i.e., inpatient, outpatient, community-based, or home-based).68 The 
incorporated trials were primarily located in Europe (59%; 37 studies) with nine 
trials conducted in the United States and three in Canada.68 Furthermore, less than 
15% of the participants were women with the sample primarily representing 
younger men post-MI or revascularization surgery.68   
Recently, the aforementioned work was scrutinized for its inclusion of out of 
date trials. Therefore, Powell and colleagues70 revised the Cochrane Systematic 
Review and meta-analysis by Anderson and colleagues68 and focused on more 
recent trials to include only those occurring in the last two decades to represent 
the time period of surgical and pharmacological advancements for CVD. Similar to 
Anderson and colleagues68, exercise-based CR did not reduce all-cause 
mortality.70 However, in contrast to Anderson and colleagues68, reduction in CVD 
mortality was no longer significant, but the authors did note a minimal reduction in 




These findings were met with resistance from the international CR 
community, with investigators around the world questioning the legitimacy of the 
work. An editorial was published in response to Powell and colleagues70 and 
implied that Powell and colleagues’ search tactics did not guarantee that the 
included trials addressed all core components of CR, and in modern CR it is 
exercise in conjunction with the other core components that yields the greatest 
benefits.71  It is also important to understand the context in which the exercise 
interventions were applied because many factors (e.g., personal, environmental, 
organizational, professional) can influence the measured outcomes, and perhaps 
certain components of the intervention are not as beneficial in specific 
circumstances.71  
Very recently, a systematic review of CR meta-analyses (published prior to 
2012)  of individuals with CAD or heart failure was conducted to determine the 
statistical and clinical (e.g., minimal important difference in a domain that an 
individual considers important and that would encourage clinicians to 
recommended CR as part of the individual’s treatment plan) evidence for CR 
outcomes.72 The meta-analyses included mostly centre-based supervised 
exercise interventions (87%; thus home or telemedicine based CR was 
underrepresented), and typically included aerobic and/or resistance training, with 
or without psychosocial and/or educational interventions.72 It was determined that 
the majority of the studies reported statistical as opposed to clinical significance, 
therefore lacked practical or clinical importance (e.g., minimal important 




enrollment by clinicians and their patients, respectively.72 Additionally, similar to 
the previously mentioned studies, there was little impact of CR on all-cause 
mortality, but a reduction in cardiovascular mortality was observed.72 Future 
research is warranted to determine the impact of modern medical management on 
all-cause mortality and the potential confounding role in CR-driven benefits.72 
Nonetheless, exercise as a cornerstone component for CR has 
demonstrated many clinical benefits. Increased cardiorespiratory fitness from 
aerobic training in CR is correlated with a reduction in blood pressure, visceral 
adiposity and systematic inflammation, and improved insulin sensitivity, 
endothelial function and psychological stress.73 Moreover, a combination of 
resistance and aerobic training in CR results in a greater decrease of body fat 
percentage and greater increases in quality of life, maximal oxygen consumption, 
fat-free mass, and both upper and lower body strength, compared to aerobic 
training alone.74 
In a related systematic review and meta-analysis, investigators sought to 
expand the exercise only focus and included recent randomised controlled trials 
that involved interventions beyond exercise to incorporate other key secondary 
prevention strategies as well.75 van Halewijn and colleagues75 determined that the 
risk of MI as well as cerebrovascular events were reduced by comprehensive CR. 
Comparable to Anderson and colleagues68, CR did not decrease all-cause 
mortality, but did reduce cardiovascular mortality.75 An important finding of this 
work was the observed relative reduction in all-cause mortality with cardiac 




to those that addressed less than six risk factors.75 This finding supports the 
previous work of Rauch and colleagues76, emphasizing the importance of a multi-
component CRP for CVD treatment.75 As such, there is a demand for further 
research regarding the effect of individual CR components and the collective effect 
on clinical outcomes.77,78 
1.2.2 History  
CR has been evolved over the last century. In the 1860’s immobilization 
was considered the most valuable treatment for MI because it was presumed to 
allow the heart to recover naturally.79 Accordingly, in the 1920’s individuals who 
suffered from an MI were urgently confined to bed rest as recovery of the heart 
was still presumed to be correlated with ample physical rest.80,81 The optimal 
duration of bed rest was at least a month and prolonged for symptomatic 
individuals, whose ordinary lives were encouraged to be delayed if required.80 
Thus, bed rest remained the predominant rehabilitation treatment for MI, enduring 
for nearly four decades.82  
During the 1950’s the validity of prolonged bed rest as a treatment for MI 
was disputed. Accumulating evidence suggested that it was unnecessary, as well 
as potentially detrimental to an individual’s physical and mental health.83,84 With 
this new stance, chair treatment or the “cardiac chair” began to evolve, which was 
predicted to be a superior method for resting the damaged heart.84 More 
specifically, within two days of an MI, individuals were transferred to a chair and 
later returned to bed when fatigue occurred.84,85 Individuals eventually remained in 




individuals began to take steps.84,85 This new form of treatment overthrew the 
impression that heart rupture or death would occur if the individual did not remain 
on bed rest.79 In reality, when compared to bed ridden individuals, those who 
underwent chair treatment during hospitalization had increased physical and 
psychological health, demonstrating a promising rehabilitation process that 
included mobilization.85–87 Eventually, it was demonstrated that participation in 
endurance activities such as swimming and hiking was “cardioprotective” and 
“rehabilitative”, revealing the necessity of not only mobilization, but exercise of all 
intensities in the rehabilitation process of the individual.88 
The goal of rehabilitation for individuals with cardiac events or conditions 
expanded beyond simply having the individuals discharged from the hospital, but 
also focused on equipping the individuals to excel in everyday life, including 
vocationally.87,89 The early objective of rehabilitation was to simply regain regular 
physical activity and independence.90 However, addressing all aspects of the 
individual’s life (e.g., physical and psychological well-being) and not solely 
economic success was said to allow an individual to live a fulfilled life.87,89 This 
new model of rehabilitation involved a non-hierarchal multidisciplinary team that 
provided an individualized program to the most significant member of the team, 
the individual with a cardiac event or condition.87,89 In essence, CR expanded 
beyond only exercise as treatment for the individual to encompass other secondary 
prevention strategies like those found in the modern CRP, such as health 
behaviour change and education, cardiovascular risk factor management, and 





Recently, an international organization, the International Council of 
Cardiovascular Prevention and Rehabilitation was founded to create a more 
homogenous model of CR around the world.92 At this time, the International 
Council of Cardiovascular Prevention and Rehabilitation is too new to provide 
global CR guidelines, however the council endorses the recent review of 
international CR guidelines by Price and colleagues.92,93 
As indicated by Price and colleagues93, the eligibility for CR is relatively 
standard throughout the world with a few nuances between countries: MI, unstable 
angina, stable angina, asymptomatic CAD, revascularisation procedures, cardiac 
valve surgery and other cardiac surgeries, pacemaker or implantable cardioverter- 
defibrillator insertion, atrial fibrillation, chronic heart failure, cardiomyopathy, 
rheumatic and congenital heart disease, cardiac transplantation, peripheral arterial 
disease, pulmonary hypertension, post cerebral vascular disease, and individuals 
with a high risk of developing CVD.  
If the focus is narrowed to specific countries, in Canada, the Canadian 
Association of Cardiac Rehabilitation or more recently named, the Canadian 
Association of Cardiovascular Prevention and Rehabilitation (CACPR) is 
responsible for national CR guidelines, including eligibility criteria, with provincial 
organizations such as CorHealth Ontario (previously the Cardiac Care Network 
(CCN)) supplying the latest guidelines. In Canada, individuals diagnosed with an 
MI or ACS, chronic stable angina pectoris, or heart failure, or who have undergone 




therapy, cardiac valve surgery, or a cardiac transplantation are most commonly 
referred to CR.22 However, the provincial level guidelines in Ontario, while following 
the national referral eligibility recommendations, also suggest that if CVD risk 
factors (e.g., hypertension, dyslipidemia) are prevalent then an individual should 
be referred to CR even if the individual has not yet had a CVD event.91  
 In the United States, eligibility for referral to CR is nearly identical to 
Canadian guidelines, with the exception that the United States guidelines do not 
mention a referral to CR following cardiac resynchronization therapy, or if CVD risk 
factors are prevalent but a CVD event has not yet occurred.17,94,95 The association 
in the United States that provides national CR guidelines is the American 
Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Likewise, 
the American Heart Association (AHA) and the American College of Cardiology 
(ACC) are also legitimate resources.  
1.2.4 Inpatient Cardiac Rehabilitation   
The progression of CR is standard throughout the world, beginning with a 
hospitalization for a coronary event, followed by a recovery period, and then on-
going rehabilitation and maintenance, although slight nuances may exist within 
each component.93 There are three common phases of CR: inpatient CR, early 
outpatient CR, and long-term outpatient or maintenance CR.22 After the 
stabilization and treatment of an acute coronary event the initiation of CR may 
commence with inpatient CR, additionally, the CACPR suggests that inpatient CR 





The preamble to inpatient CR is a chart review and a detailed interview to 
assess the individual’s medical history before beginning the core elements of 
inpatient CR, including physical activity progression and education.17 The rate of 
progression for mobilization and physical activity will be dependent on each 
individual’s diagnoses with some advancing more rapidly than others.17 When an 
individual shows a willingness to learn then education on CVD risk factor 
management and self-care should promptly begin focusing on the individual’s 
personal interests, but always addressing information related to their safety as 
well.17  
The qualified individual who delivers inpatient CR may be a nurse, 
occupational or physical therapist, exercise specialist, or another staff member 
who specializes in CR.17  The location of implementing inpatient CR can differ; 
most often taking place in an individual’s room or care unit, mobilization and 
physical activity can also occur in hospital hallways or in inpatient exercise 
rooms.17 In some instances, there may be a specific room dedicated to inpatient 
CR where individuals can undergo assessments, educational sessions and 
mobilization activities to become prepared for discharge, and referral to early 
outpatient CR.17 The CACPR and AACVPR concur it is the responsibility of the 
inpatient CR health professional to create a discharge plan for individuals, educate 
the individuals about early outpatient CR, and refer individuals to early outpatient 




1.2.5 Referral Process 
Referral to early outpatient CR is the initial step for outpatient CR 
enrollment, incorporating an order for CR based on the individual’s medical record, 
a conversation between a health professional and the individual about CR, and 
finally a CRP receiving information regarding the referral.96 The CACPR and 
AACVPR  both highlight the importance of health professionals endorsing early 
outpatient CR enrollment for eligible inpatients to encourage participation.17,22 
Furthermore, if within the previous year an individual received an eligible diagnosis 
for referral to CR in the outpatient setting, a physician or another cardiac health 
professional is responsible for referring the individual to early outpatient CR if the 
individual has not previously participated.17,22  
In Canada there is a benchmark of 30 days to enroll an inpatient in early 
outpatient CR after hospital discharge, and in the province of Ontario, within two 
weeks of receiving the referral, it is the CRP’s responsibility to contact the 
individual to schedule an intake appointment.91,97 Similarly, in the United States it 
is recommended that 1 to 3 weeks after inpatients are discharged from the hospital 
early outpatient CR should commence, with a benchmark for time to enrollment of 
21 days post hospital discharge.17,95  
The traditional or “usual” procedure for referral to CR is non-systematic and 
relies on the discretion of the physician to recommend CR and complete the 
referral.98,99 However, it is highlighted by the CACPR and AACVPR that automatic 
referral procedures should be implemented to maximize referral rates, rather than 




have a greater probability of being referred to CR when automatic referral 
procedures are employed.98–100 Automatic referrals are systematic and may 
involve electronic medical records, where a referral to CR is the default on order 
sets that healthcare professionals must uncheck, or a referral may be automatically 
sent to the CRP according to codes entered into a medical record to describe the 
individual’s health status.100,101 Additionally, an automatic referral may be paper-
based and included with hospital discharge order sets, then faxed to CR sites after 
completion.100,101 Notably, switching from manually faxed paper forms for 
automatic referral to an electronic system has been shown to increase the number 
of inpatient referrals by 17-fold.102   
Unfortunately, referral rates in both Canada and the United States remain 
suboptimal, but it has been recognized that strategies need to be employed to 
drastically increase referrals to CRPs.96,103 One of the key barriers for referrals is 
the referring physician, who may pose as a hinderance for various reasons, such 
as lack of endorsement or educated promotion of CR to patients.104–106 
Fortunately, automatic referral procedures in conjunction with a liaison to 
discuss CR with the individual before discharge can increase referrals rates to 
85.8%, compared to 70.2% for only automatic referral procedures.99 This 
emphasizes the importance of automatic inpatient referral systems and liaisons to 
educate and refer an individual to outpatient CR, and the combination of these two 
strategies to overcome barriers such as lack of physician endorsement to improve 




1.2.6 Barriers to CR Participation  
Even if optimally referred, there are many barriers that prevent individuals 
from participating in CR. Thus the utilization and completion rates for CR in both 
Canada and the United States remains suboptimal, requiring substantial 
improvement.96,103 Specific cohorts of individuals are less likely to participate in CR 
including women and older individuals.107–112 It has also been suggested that 
socioeconomic status and race or ethnicity influence participation rates, where 
individuals with a lower socioeconomic status (i.e., lower education, unemployed, 
lower income) and who identify as a minority are less likely to engage in CR.107–
110,113,114 Additionally, individuals with more comorbidities, and those who have 
been referred for an indication other than CABG are less likely to participate. 107–
110,112 Moreover, studies examining these factors provide contrasting results or 
were not sufficiently comprehensive and hence warrant further consideration in the 
modern era of CR.109 
Furthermore, individuals may not participate in CR due to accessibility 
issues (e.g., transportation and travel distance), time availability, and the cost of 
CR, the latter of which is particularly relevant in countries such as the United 
States.107,115 Conclusively, the CRP itself can be restrictive as well if services are 
limited due to facility or financial constraints.103  
Strategies have been suggested by Ades and colleagues96 to overcome 
these barriers and improve utilization and completion rates for CR. For instance, 
offering gender-tailored programming, reducing the financial expense for 




hours), evaluating performance measures to improve services offered, and 
incentives for participating (e.g., motivational, financial) are a few of the strategies 
proposed to improve utilization and completion of CR.96  
1.2.7 Intake Assessment  
Following a referral to early outpatient CR, initial contact by the CRP, and 
the completion of an intake appointment, an intake assessment including a medical 
and physical evaluation is common internationally prior to beginning early 
outpatient CR.93 Within the Canada and the United States, guidelines regarding 
the intake assessment are similar.17,22,91 Moreover, the data collected during the 
intake assessment is important to revaluate periodically throughout the duration of 
early outpatient CR and at program completion to monitor progress.17,22  
Using information obtained during the intake session, together with other 
clinical variables (e.g., cardiorespiratory fitness, metabolic fitness), an intake 
assessment determines the participant’s risk for another cardiac event and is 
especially relevant during the exercise component of CR.17,22,91 It is preferred that 
the medical and physical evaluations be performed by a physician or other health 
professional with CVD experience.17,22 Following the intake assessment, an 
individualized care plan can be developed that aligns with the participant’s goals 
and provides self-managing strategies to reduce the participant’s risk of 
CVD.17,22,91  
Firstly, the medical history should focus on the status of the participant’s 
CVD, including the participant’s risk factors and how the risk factors are being 




recommendations.17,22,91 The medical history should include past and present CVD 
symptoms, diagnoses, hospitalizations, and surgical procedures, as well as 
medications, risk factors for atherosclerotic disease progression, family history, 
and comorbidities.17,22,91  
Additionally, information should be recorded on dietary content and eating 
habits, sleep habits, physical activity or exercise patterns, alcohol consumption, 
emotional and psychosocial health, and tobacco use.17,22,91 It is also advantageous 
to address demographic information and other influences on health that may pose 
as a barrier to CR participation such as sex, age, race or ethnicity, socioeconomic 
status (i.e., level of completed education, employment circumstances, financial 
situation), and social support.17,22,91  
Secondly, the physical evaluation should assess the following: vital signs 
(e.g., pulse rate and blood pressure), anthropometrical measurements, 
cardiovascular status, respiratory status, musculoskeletal status, procedure-
related issues, and function of the lower extremities.17,22,91 Laboratory results 
including a lipid profile, glucose and glycosylated hemoglobin (HbA1c) 
measurements, and a resting 12-lead ECG are essential components of the intake 
assessment as well.17,22,91  
If the medical and physical evaluations deem it safe for a participant to 
exercise, an exercise stress test protocol will be conducted to estimate the 
participant’s cardiorespiratory fitness level (i.e., functional capacity; maximal 
oxygen consumption [VO2]).17,22 An ECG-monitored graded exercise test can be 




therefore help administer a safe and individualized exercise program.17,22,91 Very 
recently, the AACVPR stated that the most accurate exercise prescription can be 
recommended when a symptom-limited graded exercise test is conducted prior to 
CR participation, which coincides with CACPR recommendations.22,116 
Nonetheless, an exercise protocol should be determined on an individual basis as 
there are many protocols available to measure both submaximal (i.e., to estimate 
maximal VO2 by use of equations) and maximal VO2 depending on individual 
factors (e.g., disease status, age, estimated physical fitness level).3 However, 
although not as validated, another assessment such as the six-minute walk test 
can be used when graded exercise tests are unavailable or for participants with 
other limiting factors.17,22,91 Additionally, metabolic fitness (i.e., the effect of CVD 
risk factors) can be predicted by using measures such as the Framingham risk 
assessment tool.17,22 
1.2.8 Outpatient Cardiac Rehabilitation  
After completion of the intake assessment, the early outpatient CR phase 
commences. The standard duration is six months in Canada, with an average of 
two onsite sessions per week.22 While Canada does have a publicly funded health 
care system, early outpatient CR funding varies by province.103,117 Within Ontario 
the fee for early outpatient CR is typically covered by the Ontario Ministry of Health 
and Long-term Care following the success of a 2001 CR pilot project in Ontario 
that demonstrated the value of CR.118  
 In the United States, 36 onsite sessions is the standard, commonly three 




publicly funded (e.g., Medicare for participants greater than 65 years of age) or 
privately funded (e.g., purchased health care insurance), however, participants 
may still need to provide co-payments for each visit even if insured.17,96,119,120 
Evidently, if participants do not qualify for public funding or hold private funding, 
the participant may pay for CR entirely out-of-pocket.  
Once an individual is enrolled in early outpatient CR a customized, 
multifaceted, evidence-based intervention will be designed to meet the individual’s 
needs.17,22 In both Canada and the United States, the core components of 
outpatient CR are: intake assessment, risk factor modification and health 
behaviour interventions (nutritional counselling, lipid management, weight 
management, hypertension management, diabetes management, adherence to 
appropriate pharmacotherapy, tobacco cessation, psychosocial management, and 
physical activity counselling), and exercise training.17,22  
In Canada, the CACPR takes it one step further to also include, a systematic 
referral process, program adaptations for underserved populations, growth of self-
management techniques for participants, and leisure time activities as core 
components.22 The other core components stated by the CACPR are programs to 
assess outcomes, performance measures, quality improvement, and professional 
development to constantly improve program delivery.22  
The province of Ontario has an even more comprehensive description, 
stating three core CR components of: health behaviour change and education, 




psychological/psychosocial health, hypertension, dyslipidemia, dysglycemia), and 
lastly cardioprotective therapies.91  
While all the components mentioned by the CACPR are important to 
address, the AACVPR and CCN provide more up to date, simplistic core 
components, and address all other components mentioned by the CACPR 
elsewhere in the published guidelines. Nonetheless, the overall goal of outpatient 
CR is to provide lifestyle management counselling and education to encourage 
behaviour changes that may prevent a secondary cardiac event.121  
The core components of CR are fulfilled by having a multidisciplinary team 
of staff members.17,22 A medical director who is a physician is required, but other 
key personnel may include: registered nurses, exercise specialists, exercise 
physiologists, physical therapists, respiratory therapists, registered dietitians, 
mental health professionals (e.g., psychologist, social worker, or psychiatrist), 
health educators, occupational therapists, vocational rehabilitation counselors, 
clinical pharmacists, cardiovascular technicians, and other physicians.17,22 The 
multidisciplinary team allows for all-encompassing lifestyle alterations that will 
hopefully result in favourable and permanent behaviour changes.122  
Three main models of early outpatient CR delivery exist. The most 
traditional model involves supervision by the staff members previously mentioned, 
and the location is centre-based within the community (e.g., located in a hospital 
physiotherapy centre or university gymnasium).17,91,123 Centre-based deliverance 
of CR is appropriate for high-risk participants (as determined previously through 




Nevertheless, alternative models of early outpatient CR have been introduced to 
increase participation rates.17,22,123  
Two alternative or complementary models to centre-based CR are home-
based and hybrid programming.17,22 Once deemed safe, following risk 
stratification, participants can engage in home-based CR, which involves the 
majority of the participants’ exercise training completed without direct 
supervision.17,22 A home-based model limits the amount of on-site sessions 
required, but still maintains communication with the participant (e.g., telephone 
calls, regular mail) and provides follow-ups with an exercise specialist to monitor 
the participant’s exercise prescription.22  
The hybrid model serves as a transition from centre-based to home-based 
CR, involving both on-site (at least once per week) and home-based exercise 
training to monitor a participant’s safety.22 In both the home-based and hybrid 
model, the CR components beyond exercise training are still addressed, and thus 
the models serve as alternative outpatient CR models to overcome participation 
barriers (e.g., transportation, work commitments).22,124 It has been demonstrated 
that there are no significant differences for total mortality, exercise capacity, or 
HRQoL between these complementary models and centre-based CR, 
emphasizing the potential of the complementary models to increase participation 
rates.123–125  
1.2.9 Maintenance Cardiac Rehabilitation  
 The maintenance phase, recommended internationally, follows the early 




factors.17,22,93 The maintenance phase is comparable to the early CR phase, where 
the CRP is most often located within a hospital or elsewhere in the community.17,22 
Patients continue to complete an individualized secondary prevention program; 
however, there is usually less interaction with CR staff members than that received 
during initial CR programming.17  
1.3 Cardiac Rehabilitation Exercise Prescription  
Exercise training is a core component of CR around the world.93 In general, 
exercise-based CR is considered safe because of the intensive risk factor 
stratification that occurs in the previously mentioned intake assessment.17,22 
Moreover, it is safe in both the early outpatient and maintenance phase of CR.126  
Overall, the frequency, intensity, time, type, volume, and progression of 
exercise should be included in an exercise prescription for all CR participants.116 
To ensure participants are fully experiencing the benefits of CR, a participant’s 
exercise prescription must be individually progressed to continuously improve 
cardiorespiratory fitness and muscular strength, while avoiding health 
complications.116 However, only one factor of FITT (frequency, intensity, time, 
type) should be progressed at a time, and for aerobic training time or duration is 
commonly increased first.116 A progressive exercise program is appropriate for 
participants with severe CVDs and the elderly, as long as the participants have 
been approved to engage in exercise.116 There are many factors to consider when 
progressing a participant’s exercise prescription, especially the expectations and 




Regardless of a participant’s baseline level, the CACPR mentions that all 
exercise prescriptions should commence with a 5 to 10-minute warm-up at an 
intensity of 20% to 35% of the participant’s heart rate reserve (resting heart rate is 
subtracted from heart rate max (HRmax)), and conclude with a cool-down of the 
same length, but at 60% or less of the participant’s HRmax.22 Unlike the CACPR, 
the AACVPR does not provide general recommendations for a warm-up and cool-
down, but instead provides guidelines for specific populations such as those with 
heart failure and cardiac transplantations.17 
The CACPR alludes to including flexibility training in the exercise 
prescription, but lacks a frequency and intensity, whereas the AACVPR suggests 
two or three non-consecutive days per week at an intensity that is painless.17,22 
However, the CACPR does suggest holding static stretches for 15 to 60 seconds 
and completing more than four repetitions per exercise for each major muscle 
tendon group.22 Additionally, partner assisted neuromuscular facilitation 
techniques are recommended by the CACPR and are to be performed by holding 
a contraction for six seconds, shadowed by a 10 to 30 second assisted stretch.22 
Similarly, the AACVPR recommends focusing on static stretches of the lower back 
and thighs with a gradual increase in duration by holding each static stretch for 30 
to 90 seconds, for 3 to 5 repetitions.17  
1.3.1 Aerobic Training   
In early outpatient CR, aerobic training is predominant with intensity being 




training capabilities (i.e., cardiorespiratory fitness) a symptom-limited graded 
exercise test is performed to establish a safe exercise prescription.17,22  
The CACPR recommends aerobic training 3 to 5 days per week for 20 to 
40 minutes per session at 40% to 85% of heart rate reserve.22 More recent 
provincial guidelines from the CCN suggest partial recommendations for aerobic 
training, stating it should be prescribed 5 to 7 days per week incorporating at least 
30 minutes per session.91 Comparably, the AACVPR recommends aerobic training 
most days of the week (i.e., 4 to 7 days per week) for 20 to 60 minutes per session, 
at 40% to 80% of HRmax, metabolic reserve or maximal oxygen consumption.17  
Aerobic exercise training may be accomplished on electronically designed 
devices (e.g., treadmills or ergometers) or in locations that allow spacious activities 
such as walking or cycling, either indoors or outdoors.17 Essentially, rhythmic 
exercises that incorporate large muscle groups are recommended to sustain a 
healthy body weight through an increase in caloric expenditure during these 
activities.121  
1.3.2 Resistance Exercise Training 
The CACPR, AACVPR, and CCN recommend resistance training in 
conjunction with aerobic training.17,22,91 To determine resistance training 
capabilities, the gold standard is a one-repetition maximum (RM) test for each 
resistance exercise that will be completed during the exercise program.116 The 
CACPR and AACVPR both mention a 1RM test (maximal weight an individual can 
lift once) to determine baseline musculoskeletal fitness, but the protocol should be 




and rating of perceived exertion (RPE)).17,22 Additionally, the multiple RM (6RM to 
15RM; maximal weight an individual can lift 6 to 15 times) is also recommended 
by the AACVPR as a less stressful protocol compared to the 1RM.17 
The resistance training guidelines for CR recommend a frequency of 2 to 3  
days per week (the AACVPR specifies non-consecutively) including 1 to 3 sets of 
exercises encompassing both the upper and lower body.17,22 The importance of 
breathing properly and not breath holding during resistance training is emphasized 
in the guidelines.17,22 The CACPR suggests 12 to 15 repetitions of 6 to 10 different 
exercises at a RPE of 11 to 15 (Borg 6 to 20 scale), and similarly, the AACVPR 
suggests 10 to 15 repetitions of 8 to 10 different exercises at a RPE of 11 to 13 
without severe fatigue.17,22 Additionally, the CACPR suggestions that intensity can 
be quantified as 30% to 40% of a participant’s 1RM for upper body exercises, and 
50% to 60% of the participant’s 1RM for lower body exercise.22 The CACPR and 
AACVPR agree that resistance (i.e., weight) can be increased by approximately 
5% once the participant can comfortably perform the prescribed repetitions (the 
AACVPR specifies the upper limit of the repetition range).17,22 Many types of 
exercises can be performed such as those utilizing resistance bands, free weights, 
or weight machines.17  
1.3.3 Exercise Monitoring  
The degree of monitoring during exercise is determined based on pre-
programming risk stratification and clinical judgement.17,22 ECG, heart rate, blood 
pressure, and RPE (Borg Scale) are examples of variables monitored during 




The level of ECG-monitoring or telemetry (e.g., continuous to intermittent) 
that is required during exercise training can vary.17,22 For instance, in Canada it is 
at the discretion of the medical director to determine the usage, type, and length 
of telemetry monitoring, whereas in the United States, it may be mandatory for 
insurance reimbursement.17,22  
1.4 Performance and Quality Indicators 
  To ensure that involvement in CR remains safe for the participant, and to 
ensure maximum outcome, the CACPR and AACVPR state that it is necessary to 
evaluate performance measures periodically throughout program participation, 
especially before enrollment and at program completion (i.e., graduation).17,22  
The performance or quality of a CRP can be measured with evidence-based 
indicators that ensure participants are receiving the best standard of care by the 
CRPs implementing and following validated CR recommendations.95,97 More 
specifically, the Canadian Cardiovascular Society (CCS) implements evidence-
based performance measures or quality indicators to evaluate the efficiency of 
CRPs in Canada.97 The CCS established 30 quality indicators, and determined the 
“Top 5” quality indicators to be: three process indicators (percentage of eligible 
inpatients referred, number of days between receipt of referral at the CRP to 
enrollment, and percentage of enrolled individuals who received self-management 
education), one outcome indicator (percentage of CR participants who achieved a 
half metabolic equivalent increase in exercise capacity upon completion of the 





Comparatively, the AHA and the ACC recently released updated 
performance measures and quality measures to assist health professionals in the 
United States with evaluating the performance or quality of CRPs.95 The AHA and 
the ACC have subtypes of quality indicators comprising performance measures 
and quality measures.95 Performance measures are based off of scientific 
evidence and Class I clinical practice guidelines, therefore making performance 
measures appropriate to publicly report and be used for payment for performance 
programs.95 Although quality measures are important factors to evaluate, they do 
not currently have the caliber of evidence to support the usage of quality measures 
as performance measures.95  
The AHA and the ACC have established six performance measures: 
percentage of eligible referrals from an inpatient setting to CR, percentage of 
eligible referrals from an outpatient setting to CR, percentage of eligible exercise 
training referrals for heart failure from an inpatient setting, percentage of eligible 
exercise training referrals for heart failure from an outpatient setting, and 
percentage of CR enrollment both claims-based, and registry or electronic health 
records based.95  
When comparing the “Top 5” quality indicators from the CCS to the 
performance measures proposed by the AHA and ACC, the only measure that 
overlaps is the percentage of eligible referrals from an inpatient setting to CR.95,97 
Evidently, governing bodies in Canada and the United States that provide national 
guidelines for performance and quality measures may not equally value the same 




process quality indicators by the CCS, focusing on rates of referral and 
enrollment.95 While the CCS does evaluate process quality indicators related to 
referral and enrollment rates, the CCS also evaluates other factors such as self-
management education deliverance, exercise capacity changes, and the 
implementation of an emergency response strategy.97  
Furthermore, when comparing the work from Grace and colleagues127, who 
examined the Canadian Cardiac Rehab Registry (CCRR) (database for Canadian 
CRPs intake and discharge data for participants) and the work by Pack and 
colleagues128, who examined the AACVPR database (database for program 
directors of verified AACVPR CRPs), differences are presented between the 
countries for important quality indicators. For instance, Grace and colleagues127 
estimated an average wait time of 84 days, which is much more than the wait time 
of 3 to 4 weeks (21 to 28 days) for 49% of the CRPs that Pack and colleagues128 
evaluated. In contrast, the results from the CCRR indicated a higher program 
completion rate of 90%, compared to 75% for the AACVPR database.127,128 It is 
important to note the slight variation in definition of program completion (CCRR: 
some component of the CRP attended and a formal re-assessment conducted at 
the end of participation; AACVPR: each program followed a unique definition for 
program completion) between the two countries, but nevertheless comparing each 
country’s strengths and weaknesses by examining performance measures or 
quality indicators is important to determine how to improve CR utilization.127,128 
This is significant considering CRPs in both Canada and the United States have 




capacity (i.e., 100% quality), as demonstrated by Grace and colleagues and Pack 
and colleagues.127,128 
When quality indicators are monitored, and strategies are carried out to 
increase quality indicator rates, promising improvements in CR utilization are 
found. For example, a CRP at the Mayo Clinic (Rochester, Minnesota, United 
States) progressively incorporated quality improvement projects and when 
analyzing data from more than 1000 participants, the CRP’s participation rate was 
successfully increased.129 More specifically, the CRP’s two-year quality 
improvement project began by changing the program’s recommendation for 
program duration to a full dose of 36 sessions for all participants in March 2010.129 
Secondly, an informational video on CR, shown before hospital discharge and at 
the first CR early outpatient session, was applied in November 2010.129 Finally, a 
motivational program was incorporated into the early outpatient CR in July 2011, 
where participants were rewarded for attending sessions and staff were rewarded 
for high performance.129 Participants received a specific prize (e.g., parking pass, 
T-shirt, tote bag) after every sixth session attended, and staff received similar 
prizes for accomplishing tasks and promoting participant success.129 After the 
implementation of this quality improvement project, attendance for this CRP 
improved from 12 to 20 sessions per participant; in other words, there was a 40% 
improvement in attendance rates over a short two-year time frame.129 Additionally, 
the number of participants who completed 30 sessions increased from 14% to 
39%, and the number of participants who completed all 36 sessions also increased 




improvement project can be in increasing attendance and completion rates in a 
short period of time, emphasizing that CRPs should continually strive to evaluate 
and enhance program delivery.129  
The study by Pack and colleagues129 emphasizes the importance of 
frequently monitoring the performance and quality of CRPs to ensure that 
alterations are being made to consistently improve program delivery, participation, 
and the benefits that participants receive. The first step in achieving the best quality 
of CR begins by ensuring programs are legitimately recording performance 
measures or quality indicators, and from there improvement projects can be 
carried out.  
1.5 Summary of Background 
CVD is currently the leading cause of death worldwide, but the majority of 
CVD related mortality occurs from CAD, which accounted for over nine million 
global deaths in 2016.1,2 Within Canada, CAD is a major cause of death, falling 
second only to cancer, where approximately 1 in 12 (2.4 million) Canadians over 
the age of 20 years lived with CAD in 2012-2013.5 Across a national border to the 
United States, CAD is a predominant cause of death currently accounting for 
43.8% of the lives lost to CVD.7  
 CR is a secondary prevention strategy delivered by a multidisciplinary team 
of health professionals, with a focus on lifestyle interventions to manage the 
modifiable risk factors associated with CVD and ultimately CAD.69 Exercise-based 





These benefits are delivered by utilizing the core components of CR to 
improve an individual’s disease status.17,22 Consequently, outcome assessments 
are necessary to ensure the efficacy of a CRP to deliver benefits to the 
participant.17,22 The CCS, and the AHA in conjunction with the ACC, have formally 
provided quality indicators for CRPs in Canada and the United States to be 
evaluated, respectively.95,97 Despite the necessity of CR, CRPs in Canada and the 
United States have yet to create a standard of care where all quality indicators 
(e.g., CR enrollment and completion) are being fulfilled to capacity (i.e., 100% 
quality).127,128  
In fact, CR utilization and completion rates in both the Canada and the 
United States remain suboptimal.96,103 Moreover, specific populations are less 
likely to participate in CR (e.g., women, older individuals) and an array of other 
barriers exist (e.g., transportation, financial constraints) that prevent individuals 
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Chapter 2:  
A Comparison of Cardiac Rehabilitation Services and Outcomes in the 
Great Lakes Central Region  





Cardiovascular disease (CVD) is currently the leading cause of death 
worldwide, with the majority of CVD-related deaths occurring from coronary artery 
disease (CAD), which accounted for over 9 million global deaths in 2016.1,2 Within 
Canada, CAD is a major cause of death, second only to cancer, where 
approximately 1 in 12 (2.4 million) Canadians over the age of 20 years lived with 
CAD in 2012-2013.3 Across a national border to the United States, CAD is a 
predominant cause of death currently accounting for 43.8% of the lives lost to 
CVD.4 
 Cardiac rehabilitation (CR) is a secondary prevention strategy delivered by 
a multidisciplinary team of health professionals, with a focus on lifestyle 
interventions to manage the modifiable risk factors associated with CVD and 
ultimately CAD.5 Exercise-based CR has been shown to improve clinical outcome 
and health-related quality of life (HRQoL) in individuals with CAD.6  
These benefits are delivered by utilizing the core components of CR to 
improve a participant’s disease status.7,8 Consequently, outcome assessments are 
necessary to ensure the efficacy of a cardiac rehabilitation program (CRP) to 
deliver benefits to the participants.7,8 The Canadian Cardiovascular Society, and 
the American Heart Association in conjunction with the American College of 
Cardiology, have formally provided quality indicators for CRPs in Canada and the 
United States to be evaluated, respectively.9,10 Despite the necessity of CR, CRPs 
in Canada and the United States have yet to create an ideal standard of care where 




capacity (i.e., 100% quality).11,12 In fact, utilization and completion rates in both the 
Canada and the United States are suboptimal.13,14 Moreover, specific populations 
are less likely to participate in CR (e.g., women, older individuals) and an array of 
other barriers exist (e.g., transportation, financial constraints) that prevent 
individuals from participating in and completing CR. 14–23 
2.2 Purposes and Hypotheses 
CR improves clinical outcomes and HRQol in individuals with CAD. Despite 
this CR is underutilized around the world, including in Canada and the United 
States. Further, the degree of benefit in clinical subgroups and optimal duration 
and program content are not clear. Thus, the ultimate goal is to create a CR model 
(or models) that provide(s) the greatest level of care and outcomes for all 
participants. As a first step in this process, the purpose of this study was to 
compare models of care from four geographically close CR sites that span an 
international border through examination of program characteristics and database 
variables. Additionally, the participants were characterized and examined for 
potential predictors of program completion at one site. It is hoped that this latter 
work will lay a foundation for a larger-scale study spanning all four CR sites. 
The following specific objectives were pursued in two phases:  
Phase 1 - Objective 1:  Describe the similarities and differences in program 
characteristics (e.g., referral procedures, psychosocial services offered) between 
and within Canadian-based (two sites) and United States-based (two sites) CRPs.  
Objective 2: Determine common and unique database variables collected by the 




Phase 2 - Objective 3: Determine factors that impacted graduation (i.e., program 
completion) at one of the CR sites.  
Hypothesis: It was hypothesized that the participants would be younger 
individuals who were Caucasian (used interchangeably with White; African 
American used interchangeably with Black) men with higher socioeconomic 
status (i.e., higher education and employed), no comorbidities, and had 
coronary artery bypass grafting (CABG) as an indication for referral.14–23 It 
was further hypothesized that age, sex (used interchangeably with gender), 
race, education, occupation status, comorbidities, and referral indication 
would impact program completion.14–23 
2.3 Clinical Significance 
CAD is the leading cause of mortality worldwide.2 The weight of the 
evidence suggests that CR reduces cardiovascular disease-related deaths and 
hospitalizations, and improves HRQoL .6 Despite this, CR is underutilized around 
the world, including in Canada and the United States. Furthermore, a standardized 
model of care is not implemented internationally. Therefore, by comparing the 
granular details of CR sites (e.g., program characteristics and database variables) 
within and between countries in close geographical proximity, an ideal CR model 
or models that increase rates of participation and program completion can be 
fostered. Moreover, preliminary identification of participant characteristics and 
associated barriers to program completion will frame the objectives for a broader 





This study included four CR sites in the Great Lakes Central Region of North 
America: two from Southwestern Ontario (Canada) and two from Southeastern 
Michigan (United States). The University of Windsor (PACR Laboratory, 
Department of Kinesiology, Faculty of Human Kinetics, Windsor, Ontario, Canada) 
was deemed the central academic site. As described above in Section 2.2, this 
study occurred in two phases. Phase 1 compared program characteristics and 
database variables from all CR sites, while Phase 2 involved a single-site 
retrospective database analysis. This study was cleared by all institutional 
research ethics boards, which was captured under the master University of 
Windsor’s Research Ethics Board (REB # 19-001/35602) clearance. 
2.4.1 Phase 1 
All four sites sent individual site program characteristics via secure email 
and the program characteristics from each site were compiled into one master 
Excel document housed at the University of Windsor. All four sites also sent 
individual data dictionaries (either in WORD or Excel) via secure email, which were 
compiled into one master Excel document housed at the University of Windsor.  
2.4.2 Phase 2 
De-identified data from thousands of historically consented participants who 
attended an early outpatient CRP in Michigan (Michigan Site #2) between 2012 – 
2016 were extracted from the site’s database and shared by secure file transfer 
with the University of Windsor (PACR Laboratory, Department of Kinesiology, 




by qualified CR research personnel at the site prior to transfer to the University of 
Windsor (PACR Laboratory, Department of Kinesiology, Faculty of Human 
Kinetics). Embedded in the de-identified data was no more than four HIPAA 
identifiers. The HIPAA identifiers included in the database were: ZIP code, sex, 
age, and race. To account for the inclusion of the HIPAA identifiers, a Data Sharing 
Agreement was created to maintain participant confidentiality and anonymity.  
2.5 Statistical Analysis  
2.5.1 Phase 1  
The information collected from the program characteristics and data 
dictionaries did not require statistical analysis. These variables were compared 
qualitatively to determine similarities and differences. A database variable was 
considered to be common if at least two of the four sites (i.e., 50%) included it in 
their data dictionaries, and a database variable was considered to be unique if only 
one of the four sites included it in their data dictionary. Database variables were 
examined according to the Canadian Association of Cardiovascular Prevention 
and Rehabilitation (CACPR) and American Association of Cardiovascular and 
Pulmonary Rehabilitation (AACVPR) guidelines, which recommend valuable 
aspects to address and collect.7,8 
2.5.2 Phase 2  
 The sample used for analyses was composed of first-time CR participants. 
Following data cleaning procedures (identification of duplicate and anomaly 
cases), descriptive statistics were conducted to characterize the population. 




comorbidities, and referral indication) were assessed according to graduation 
status (graduated or not graduated) using an independent-samples t-test and chi-
squared tests as appropriate to determine the factors that impacted program 
completion from the early outpatient CRP in Michigan. Subsequent one-way 
ANOVAs were conducted on occupation status and comorbidities to determine if 
age was statistically different between the categories of these variables. 
Univariate analyses were used to determine the predictor variables included 
in the logistic regression. An independent-samples t-test demonstrated a 
significant difference in age between participants who were graduated and not 
graduated. Additionally, education, occupation status, and comorbidities were 
found to have significant associations with graduation status according to chi-
squared tests and as such, age and these variables were included in the logistic 
regression as predictor variables. As referral indication revealed no significant 
association with graduation status and since it was comprised of several (10) 
categories that could not be collapsed into smaller categories, it was not included 
as a predictor variable. However, even though sex and race did not exhibit 
significant associations with graduation status, these variables were included in 
the analysis because of the potential for them to have joint predictive ability with 
the other variables. Subsequently, an enter-method logistic regression with 
graduation status (graduated or not graduated) as the outcome and participant 
characteristics (age, sex, race, education, occupation status, and comorbidities) 




impacted program completion. Data are presented as mean ± standard deviation, 
unless otherwise stated.  
 For the independent-samples t-test and one-way ANOVAs, outliers were 
assessed by inspection of boxplots and z-scores, and normal distribution was 
assessed by histograms, normal Q-Q plots, skewness, and kurtosis were 
appropriate. Additionally, homogeneity of variance was assessed by Levene’s test 
for equality of variance. For the chi-squared tests, all expected cell frequencies 
were inspected to be greater than five for 2 by 2 contingency tables. For larger 
tables, all expected cell frequencies were inspected to be greater than one and no 
more than 20% were less than five. For the logistic regression, outliers were 
assessed with standardized residuals and Cook’s Distance. Additionally, linearity 
of the log odds transformation (logit) of the dependent variable with respect to the 
continuous independent variable (age) (Box-Tidwell procedure), and 
multicollinearity (tolerance values, VIF values, and correlation coefficients) were 
assessed.  
 Statistical analyses were performed with IBM SPSS Statistics 25.0 (IBM 
Corp, Armonk, New York) and statistical significance was p ≤ 0.05.  
2.6 Results  
2.6.1 Phase 1 – Objective 1: Program Characteristics Description  
In brief, all CR sites were affiliated with a hospital and governed by their 
respective health care systems, and most were affiliated with a university. The 
Ontario sites had no program fee whereas the Michigan sites did. The Ontario sites 




months. Similarly, the Michigan sites averaged two to three weekly onsite 
sessions, but the average range of program duration was typically less than the 
Ontario sites. Please see Table 1 for details. 
Table 1: Program Overview 
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan Site #2 
Hospital 
Affiliation 
Yes Yes Yes Yes 
University 
Affiliation 
Yes Yes No Yes 














Ministry of Health/ 
Government 
 





































6 months 6 months 8-18 weeks 12-18 weeks 
 
With respect to eligibility for referral there were many common diagnoses 
accepted across the sites. An Ontario site accepted diagnoses that no other sites 
accepted, as did the Michigan sites. Neither site in Ontario accepted “having (a) 
CVD risk factor(s) only (e.g., hypertension but with no CVD event)”. Please see 





Table 2: Eligibility for Referral 




Myocardial Infarction Yes Yes Yes Yes 
Acute Coronary 
Syndrome 
Not specified Yes Not specified Not specified 
Stable Angina 
Pectoris 
Yes Yes Yes Yes 
PCI/Stent Yes Yes Yes Yes 
CABG Yes Yes Yes Yes 
Valve 
Repair/Replacement 
Yes Yes Yes Yes 
Congestive Heart 
Failure 
Yes Yes Yes Not Specified 
Systolic Heart Failure Not specified Not specified Not specified Yes 
LVAD Not specified Not specified Yes Not specified 
Heart Transplant Yes Yes Yes Yes 
Congenital Heart 
Disease 
Not specified Yes Not specified Not specified 
Other Cardiac 
Diagnoses† 
Not specified Yes Not specified Not specified 
Symptomatic PAD Not specified Not specified Yes Not specified 
†Cardiac arrhythmia, implantable cardioverter-defibrillator, pacemaker, cardiomyopathy 
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; LVAD, left 
ventricular assist device; PAD, peripheral arterial disease 
 
Sites utilized a variety of automatic referral procedures, and there were 
nuances between and within countries. Please see Table 3 for details. 
Table 3: Referral Details 
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan Site #2 
Procedure Automatic referral 












for inpatients at 
affiliated hospital 
or outpatients at 
affiliated 
physician office; 






























 All sites delivered the majority of core CR components to participants, but 
one Michigan site did not offer pharmacotherapy management and the other 
Michigan site did not offer tobacco cessation. None of the sites offered participation 
incentives to participants. Please see Table 4 for details. 
Table 4: Core Components  
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan Site #2 
Exercise Training Yes Yes Yes Yes 
Nutritional 
Counselling 
Yes Yes Yes Yes 
Psychosocial 
Management 
Yes Yes Yes Yes 
Pharmacotherapy 
Management 
Yes Yes No Yes 
Tobacco 
Cessation 
Yes Yes Yes No 
Other Risk Factor 
Modification 
Yes Yes Yes Yes 
Participation 
Incentives  
No No  No No 
 
 All sites conducted an entry exercise test; however, one Michigan site did 
not conduct this test on all participants. An Ontario site estimated maximal oxygen 
consumption (VO2) whereas the other three sites measured maximal VO2. The 
Michigan sites used telemetry during exercise sessions with slight nuances 
between the two sites, while the Ontario sites did not use telemetry during exercise 





Table 5: Exercise Training Details 






Michigan Site #2 
Entry Exercise Test Yes Yes Yes; ~ 50% of 
the time when 
determined to be 







Yes Yes Yes 
ECG Monitoring/ 
Telemetry 
No No Yes; first 3 
sessions then 
discontinued; 
restart if clinical 
need 
Yes; transition to no 
monitoring if no 
signs/symptoms and 
insurance approves 
†Measured maximal VO2 is when individuals perform exercise test protocols to determine maximal 
VO2, whereas with estimated individuals do not reach maximal VO2, but instead reach submaximal 
VO2 and maximal VO2 is estimated with equations 
VO2, oxygen consumption; ECG, electrocardiogram 
 
All sites collected data at intake and graduation. Three of the sites also 
collected data during programming but there was variation in the quantity collected. 
Only one site, located in Michigan, collected follow-up data. Please see Table 6 
for details. 
Table 6: Data Collection Time-Points 
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan Site #2 
Intake Yes Yes Yes Yes 
During 
Programming 









and exit when 
warranted; all-
encompassing 
similar to intake 
assessment  




Graduation Yes Yes Yes Yes 
Follow-up No No No Yes; at 1,6,12 months 
after graduation and 
every 6 months after 
the year mark; 









All sites had a physician as the medical director. There was variation across 
the sites in regard to the number of staff members for each occupation. However, 
only one site in Ontario had a psychologist on staff. Please see Table 7 for details. 
Table 7: Staff Members  
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan Site #2 






































50% of education 
classes 




Dietitian 1 on staff; 
participant 
interaction varies; 





2 on staff; 
participant 
interaction varies; 
at intake for 
everyone, 2-3 
visits for other 
participants 





remaining 50% of 
education classes 

















1.5 on staff; 
participant 
interaction varies 
0 on staff; 
referred to as 
needed by CR 
staff members 




Psychologist 0 on staff 1.5 on staff; 
participant 
interaction varies; 
~8 visits for those 
who referred by 
CR staff 
members 
0 on staff; 
referred to as 
needed by CR 
staff members 
0 on staff; 
referred to as 
needed by CR 
staff members 
Nurse 1 on staff; 
participant 
interaction at 
intake, 3 months, 
6 months for 
everyone; could 















0 1; participant 
interaction as 
needed 
The number of staff members are totals without specification of full-time or part-time positions  




 Three of the sites offered home-based programming and the site that did 
not was located in Michigan. For the sites that offered home-based programming, 
there was variation across the sites regarding the details, with the largest 
difference existing between the Ontario sites and the Michigan site. Please see 
Table 8 for details. 
Table 8: Home-Based Programming 
 Ontario Site #1 Ontario Site #2 Michigan Site #1 Michigan 
Site #2 
Available for All 
Participants 
Yes Dependent on 
self-efficacy for 
exercise as 
determined by CR 
staff members 
Yes No 
Frequency of On-site 
Sessions 
Once monthly See below Individualized N/A 
Check-ins No; only if 
participant calls 
May receive 
phone, email, or 
check-in visits by 
CR staff members 
Individualized N/A 







CR Staff Members 




audio and video 
conference 
N/A 
Program Fee No No Yes; same as on-
site, but coverage 




Core Component(s) Exercise training Exercise training Exercise training N/A 

















2.6.2 Phase 1 – Objective 2: Common and Unique Database Variables 
Common Variables Collected at Intake 
Referral and General Intake  
 There were no referral and general intake variables that were collected 
across all four sites, however, the sites in Ontario collected the point of referral 
(e.g., inpatient unit, emergency room, physician office) and date of the referral.  
Medical History  
 All sites collected the event or indication for referral to early outpatient CR, 
the diagnoses of hypertension and diabetes, and prescribed medications. Three 
sites (two Ontario sites and a Michigan site) collected diagnoses of hyperlipidemia, 
pulmonary or respiratory diseases (including sleep apnea), cerebrovascular 
diseases, and bone and joint or musculoskeletal impairments or diseases. Two 
sites (one Ontario and one Michigan) collected CVD information beyond that 
collected to determine indication for referral to CR. The sites in Ontario collected 
depression as an event or indication (i.e., diagnoses) for referral, primary CVD risk 
factors, additional risk factors, medication relevant diagnoses, sensory 
impairments, neurological diseases, and diagnosis of erectile dysfunction.  
Physical Activity or Exercise Patterns  
 There were no variables that were collected across all four sites. Three sites 
(two Ontario sites and a Michigan site) collected musculoskeletal limitations to 
exercise. The Ontario sites also collected other non-cardiac limitations to exercise 





Alcohol Consumption  
 There were no variables that were collected across all four sites. Three sites 
(two Ontario sites and a Michigan site) collected the current status of the 
participant drinking alcohol, the amount, and various questions related to the 
excessive use of alcohol.  
Tobacco Use  
 All sites collected the current status of the participant smoking tobacco. 
Three  sites (two Ontario sites and a Michigan site) collected the amount smoked 
per day and the smoking tobacco quit date, if applicable. The sites in Ontario 
collected the frequency of smoking tobacco and the number of years smoking 
tobacco.  
Demographic Information  
 All sites collected a variation of demographic variables at intake. More 
specifically, all sites collected address, date of birth or age, sex or gender, and 
race or ethnic group. Three sites (two Ontario sites and a Michigan site) collected 
marital status, living situation (e.g., alone, with spouse, with children), education, 
occupation, and current occupation status (e.g., active, unemployed, retired). The 
sites in Ontario also collected desired occupation status, spoken language, and 
type of residence (e.g., home, apartment, acute care hospital).  
Travel Time  
 There were no variables that were collected across all four sites, however 





Physical Evaluation  
All sites collected blood pressure, weight, height, and a variation of 
dysrhythmia history. Three sites (two Ontario sites and a Michigan site) collected 
ejection fraction and laboratory results including a lipid profile, and glucose and 
glycosylated hemoglobin (HbA1c) measurements. The sites in Ontario collected 
resting ankle blood pressure, resting heart rate, other blood components, the 
Canadian Cardiovascular Society angina grade, and the New York Heart 
Association heart failure class. 
Exercise Test  
 All sites collected the exercise test protocol used, the exercise test duration, 
peak blood pressure (systolic and diastolic), heart rate during the exercise test, 
and measured functional capacity by collecting maximal VO2 or peak oxygen 
uptake (ml/kg/min) (estimated or measured). Additionally, all sites collected some 
variation of signs and symptoms that occurred during the exercise test, including 
electrocardiogram (ECG) changes with a focus on ischemia/ST changes and 
evidence of angina. Three sites (two Ontario sites and a Michigan site) collected 
rating of perceived exertion (utilizing a variation of the Borg Scale) during the 
exercise test and the reason that the exercise test was terminated. The sites in 
Ontario collected the exercise test location (on-site, off-site, elsewhere), resting 
blood pressure (systolic and diastolic) and heart rate before the exercise test, and 
lung function (e.g., normal, mild, obstructive disease).  
It should be noted that some of the variables collected with exercise tests, 




relevant to the Medical History and Physical Evaluation as well. As such, the 
variables have been included in these headings. Nonetheless, consideration 
needs to be made regarding the fact that if an exercise test is not conducted, this 
information may not be collected or may be collected in a format not captured by 
the current data dictionary. 
Questionnaires  
Overall Health Related Questionnaires  
There were no common questionnaires collected.  
Psychological Health Related Questionnaires  
 There were no psychological health related questionnaires that were 
collected across all four sites. The sites in Ontario collected the Hospital Anxiety 
and Depression Scale (HADS).   
Physical Health Related Questionnaires  
There were no common questionnaires collected. 
Nutrition Related Questionnaires  
There were no common questionnaires collected. 
Staff Members 
 There were no variables that were collected across all four sites, but three 
sites (two Ontario sites and a Michigan site) collected the case manager. The sites 
in Ontario collected if a nurse practitioner was required and the type of care (e.g., 






Unique Variables Collected at Intake 
 For a summary of the unique variables collected at intake please see Table 
9 below. 









Referral and General Intake 
- First early outpatient CR visit that is 
billable   a  
- Previous CR participation    a 
Medical History 
- Background events impairing 
cardiovascular health  a   
- Allergies  a   
- Signs and symptoms of cardiac 
conditions    a 
- General fatigue     a 
- Cancer    a 
- Gastrointestinal    a 
- Genitourinary    a 
- Neuropsychiatric (e.g., depression, 
anxiety)    a 
- Hematology    a 
- Pregnancy history    a 
- Gynecological history    a 
- Family history    a 
- Body weight history and eating 
habits†    a 
     Physical Activity or Exercise Patterns  
- Type of exercise performed (cardio 
or strength training)    a 
- Amount for each type of exercise    a 
- Accessibility to exercise equipment 
at home    a 
- Membership to a gym    a 
     Alcohol Consumption  
- Motivation to quit drinking alcohol 
(0-10 scale)    a 
     Tobacco Use 
- Number of quitting attempts  a   
- Acceptance of inpatient or 
outpatient smoking cessation 
services 
 a   
- Type of tobacco smoked 
(cigarettes, cigars, pipe, smokeless 
tobacco) 
   a 
- Amount each type of tobacco is 
used    a 
- Quit date for each type of tobacco    a 
- Motivation to quit smoking (0-10 




- Status of a participant living with 
someone who smokes    a 
Demographic Information  
- Insurance information   a  
- Religion    a 
- Rating of one’s marriage (e.g., 
excellent, poor)    a 
- Number of children    a 
- Social support (i.e., the main 
source and the rating for the 
amount received) 
   a 
Physical Evaluation  
- Framingham risk score  a   
- Fall related questions a    
- Body composition    a 
- Criteria for metabolic syndrome    a 
- Electrocardiogram evidence of left 
ventricular hypertrophy    a 
- Myocardial infarction or cardiac 
surgery complicated by cardiogenic 
shock 
   a 
- Coronary angiography and 
obstruction details    a 
- Lower and upper heart range   a  
- Indication for use of rating of 
perceived exertion only   a  
Exercise Test 
- Reason for the exercise test (i.e., 
for early outpatient cardiac 
rehabilitation or not) 
 a   
- Supine blood pressure (systolic and 
diastolic) and heart rate  a   
- Standing blood pressure (systolic 
and diastolic) and heart rate  a   
- Test type in regard to estimated or 
measured functional capacity     a 
- 6-minute hall walk results    a 
- Specific signs and symptoms 
included arrhythmia information 
and systolic blood pressure 
response (e.g., hypo, blunted) 
   a 
Questionnaires 
     Overall Health Related Questionnaires 
- Short Form (12) Health Survey (SF-
12)  a   
- Short Form (36) Health Survey 
Version 2.0  (SF-36 V2)    a 
- Dartmouth COOP Health Survey   a  
     Psychological Health Related Questionnaires 
- Patient Health Questionnaire 
(PHQ-9)   a  
- Brief Symptom Inventory (BSI-53)    a 
     Physical Health Related Questionnaires 
- Duke Activity Status Index (DASI)  a   
- Human Activity Profile (HAP)  a   
     Nutrition Related Questionnaires 




- Customized Food Frequency 
Survey/Assessment    a 
† Database variables included: a healthy weight the participant considered for themselves, previous or 
current weight-loss programs, previous dietician counselling, motivation, confidence and obstacles to 
implementing improvements in diet 
 
Common Variables Collected During Programming  
Attendance  
 There were no variables that were collected across all four sites. The sites 
in Ontario collected attendance rates for specific core components including: 
attendance for cardiac education (independent and group), diabetes education, 
dietary counselling (independent), dietary education (group), exercise counselling 
(independent), exercise education (group), medication counselling (independent 
and group), psychosocial education (group), stress management (group), 
supervised exercise, home-based exercise, smoking cessation, psychology 
services, social work services, women’s support group, vocational assessment 
and counselling, and pharmacotherapeutic sessions. The sites in Michigan 
collected the total number of early outpatient CR sessions attended.  
Unique Variables Collected During Programming  
For a summary of the unique variables collected during programming 
please see Table 10 below. 










- Exercise training days per 
week a    
- Total electrocardiogram 
monitored sessions   a  
- Number of sessions approved    a 
- Number of sessions prescribed    a 





Common Variables Collected at Graduation 
Medical History  
There were no variables that were collected across all four sites. Three sites 
(two Michigan sites and an Ontario site) collected prescribed medications. Three 
different sites (two Ontario sites and a Michigan site) collected the presence of 
hypertension. The Ontario sites collected if participants were sedentary, had high 
blood cholesterol, or psychological concerns at graduation, and if the participants 
were going to attend pulmonary rehabilitation.  
Physical Activity or Exercise Patterns 
 There were no variables that were collected across all four sites. The sites 
in Michigan collected exercise frequency.  
Alcohol Consumption  
There were no variables that were collected across all four sites. An Ontario 
site and a Michigan site collected the current status of the participant drinking 
alcohol, the amount, and various questions related to the excessive use of alcohol.  
Tobacco History 
 There were no variables that were collected across all four sites. Three sites 
(two Michigan sites and an Ontario site) collected the current status of the 
participant smoking tobacco. An Ontario and a Michigan site collected the amount 
smoked per day. 
Demographic Information  
 There were no variables that were collected across all four sites. The 




Physical Evaluation  
All sites collected resting blood pressure. Three sites (two Michigan sites 
and an Ontario site) collected weight. An Ontario and Michigan site collected 
laboratory results including a lipid profile, glucose, and glycosylated hemoglobin 
(HbA1c) measurements, and resting heart rate. 
Exercise Test 
 All sites conducted an exercise test at graduation and collected relative 
variables. Please refer to Exercise Test under Variables Collected at Intake for 
more detail.  
It should be noted that some of the variables collected with exercise tests, 
which can occur at different time-points and not for every participant, could be 
relevant the Medical History and Physical Evaluation as well. As such, the 
variables have been included in these headings. Nonetheless, consideration 
needs to be made regarding the fact that if an exercise test is not conducted, this 
information may not be collected or may be collected in a format not captured by 
the current data dictionary. 
Questionnaires  
Overall Health Related Questionnaires  
There were no common questionnaires collected.  
Psychological Health Related Questionnaires  
There were no common questionnaires collected. 
Physical Health Related Questionnaires  




Nutrition Related Questionnaires  
There were no common questionnaires collected. 
Program Evaluation Questionnaire  
There were no common questionnaires collected. 
Reason for Graduation  
 There were no variables that were collected across all four sites. Three sites 
(two Ontario sites and a Michigan site) collected the reason a participant graduated 
or ceased to attend CR (e.g., completed program, insurance, return to work). 
Unique Variables Collected at Graduation 
For a summary of the unique variables collected at graduation (i.e., program 
completion) please see Table 11 below. 










- Lower limb claudication  a   
- Pulmonary or respiratory diseases  a   
- Cerebrovascular diseases  a   
- Bone and joint or musculoskeletal 
impairments or diseases  a   
- Sensory impairments  a   
- Neurological diseases  a   
- Erectile dysfunction  a   
- Allergies  a   
- Signs and symptoms of cardiac 
conditions    a 
- Cardiac events or tests since the 
participant’s previous evaluation    a 
- Gynecological history    a 
- Diabetes   a  
     Physical Activity or Exercise Patterns  
- If strength training was being performed    a 
- Accessibility to exercise equipment at 
home    a 
- Membership to a gym    a 
- Participant’s exercise plan following 
graduation   a  
     Alcohol Consumption  
- Motivation to quit drinking alcohol (0-10 
scale)    a 




- Frequency of smoking tobacco  a   
- Number of years smoking tobacco  a   
- Number of quitting attempts  a   
- Smoking tobacco quit date  a   
- Type of tobacco smoked (cigarettes, 
cigars, pipe, smokeless tobacco)    a 
- Amount each type of tobacco is used    a 
- Motivation to quit smoking (0-10 scale)    a 
- Obstacles to quitting    a 
- Tobacco products quit in the last 6 
months    a 
- Status of a participant living with 
someone who smokes    a 
Physical Evaluation  
- Resting ankle blood pressure  a   
- Resting heart rate  a   
- Blood components beyond lipid profile, 
glucose, and glycosylated hemoglobin 
(HbA1c) 
 a   
- Canadian Cardiovascular Society 
angina grade  a   
- New York Heart Association heart 
failure class  a   
- Ejection fraction  a   
- Dysrhythmia history  a   
- Body composition   a  
Questionnaires 
     Overall Health Related Questionnaires 
- Short Form (12) Health Survey (SF-12)  a   
- Short Form (36) Health Survey Version 
2.0  (SF-36 V2)    a 
- Dartmouth COOP Health Survey   a  
     Psychological Health Related Questionnaires 
- Hospital Anxiety and Depression Scale 
(HADS)  a   
- Patient Health Questionnaire (PHQ-9)   a  
- Brief Symptom Inventory (BSI-53)    a 
     Physical Health Related Questionnaires 
- Duke Activity Status Index (DASI)  a   
- Human Activity Profile (HAP)  a   
     Nutrition Related Questionnaires 
- Rate Your Plate   a  
- Customized Food Frequency 
Survey/Assessment    a 
     Program Evaluation Questionnaire 
- Customized Patient Satisfaction Survey   a  
Behaviour Modification/Program Compliance Problems 
- Taking medications    a 
- Getting regular exercise    a 
- Quitting smoking    a 
- Eating correctly    a 
- Controlling body weight    a 
- Drinking alcohol in moderation or not at 
all    a 





2.6.3 Phase 2 – Objective 3: Michigan Site Data Analysis  
Data cleaning identified no duplicate cases, but one anomaly case was 
removed from the sample producing the final sample size of 1265 CR participants.  
Characterization of Population  
 Participants were predominately Caucasian (n = 1044), men (n = 896), 
university educated (n = 633), and not actively employed (n = 634). More than one 
half of the population had two or more comorbidities (n = 749). The three most 
common referral indications were percutaneous coronary intervention (PCI)/Stent 
(n = 312), myocardial infarction (MI) (n = 272), and valve replacement/repair (n = 
207). Please see Table 12 for details. 
Table 12: Participant Characteristics   
Total Sample 
(N = 1265) 
Age (years; mean ± SD) 62.51 ± 11.81 
Sex (n; % of total sample) 
 
Women 369 (29.2%) 
Men 896 (70.8%) 
Race (n; % of total sample) 
 
Caucasian 1044 (82.5%) 
African American 86 (6.8%) 
Other 135 (10.7%) 
Education† (n; % of total sample) 
 
University 633 (50.1%) 
College/Post-Secondary 378 (29.9%) 
High School or Less 187 (14.8%) 
Unknown 65 (5.1%) 
Occupation Status (n; % of total sample) 
 
Active 574 (45.4%) 
Retired 510 (40.3%) 
Unemployed 40 (3.2%) 
Medically Disabled 84 (6.6%) 
Unknown 57 (4.5%) 





No Comorbidity 221 (17.6%) 
1 Comorbidity 287 (22.8%) 
2 Comorbidities 350 (27.8%) 
>2 Comorbidities 399 (31.7%) 
Referral Indication (n; % of total sample) 
 
PCI/Stent 312 (24.7%) 
MI 272 (21.5%) 
Valve Replacement/Repair 207 (16.4%) 
CABG 185 (14.6%) 
MI/PCI 157 (12.4%) 
Heart Failure 50 (4.0%) 
CABG/Valve Replacement/Repair 28 (2.2%) 
Stable Angina  26 (2.1%) 
Heart Transplant 5 (0.4%) 
Other 23 (1.8%) 
†Education had 2 (0.2%) system missing cases 
‡Comorbidities had 8 (0.6%) system missing cases 
SD, standard deviation; PCI, percutaneous coronary intervention; MI, myocardial infarction; CABG, 
coronary artery bypass grafting  
 
Participant Factors and Program Completion  
Program completion or graduation for a participant was classified as the 
participant attending at least 75% of the CR sessions that were prescribed to the 
participant. The number of prescribed sessions varied according to the number of 
sessions approved by insurance, which is typically 36 sessions. Most participants 
in the current sample (64.4%) were prescribed 36 sessions. Graduation status 
(graduated or not graduated) was not recorded for two participants from the 
original sample (N = 1265), consequently the final sample size was 1263 
participants. There were 321 (25.4%) non-graduates and 942 (74.6%) graduates. 






Comparison of Graduation Status and Age 
An independent-samples t-test revealed a significant difference in age 
between non-graduates and graduates. Non-graduates (60.47 years ± 12.44) were 
significantly younger than graduates (63.21 years ± 11.52) [difference = -2.74 
years (95% confidence interval [CI], -4.23 to -1.24); t(1261) = -3.599, p < 0.0005].    
Comparison of Graduation Status and Sex 
A chi-squared test revealed no significant association between graduation 
status and sex (men or women), χ2(1) = 0.004, p = 1.00.  
Comparison of Graduation Status and Race 
A chi-squared test revealed no significant association between graduation 
status and race (Caucasian, African American, and other [Asian, Hispanic, Middle 
Eastern, Native American, South East Asian, other, unknown]), χ2(2) = 0.087, p = 
0.958. 
Comparison of Graduation Status and Education 
 A chi-squared test revealed a significant association between graduation 
status and education (university [bachelor’s degree, some post graduate, master’s 
degree, PhD, and medical doctor], college/post-secondary [some college, trade 
school, and associate’s degree], high school or less [some high school and high 
school/GED], and unknown), χ2(3) = 35.887, p < 0.0005. The proportion of 
graduates (54.9%) with university education was significantly more than those that 
did not graduate (36.3%). The proportion of graduates with college/post-secondary 
education (27.4%) or high school or less education (12.6%) was significantly less 




Comparison of Graduation Status and Occupation Status 
A chi-squared test revealed a significant association between graduation 
status and occupation status (active, retired, unemployed, medically disabled, and 
unknown), χ2(4) = 22.786, p < 0.0005. The proportion of graduates (42.6%) that 
were retired was significantly more than the proportion that did not graduate 
(33.6%). The proportion of graduates that were medically disabled (4.9%) was 
significantly less than the proportion that did not graduate (11.5%). 
Comparison of Graduation Status and Comorbidities 
A chi-squared test revealed a significant association between graduation 
status and number of comorbidities (none, one, two, and greater than two), χ2(3) 
= 8.607, p = 0.035. The comorbidities included any type of cancer, hypertension, 
high blood cholesterol, bronchitis (as a measure of COPD), emphysema (as a 
measure of COPD), stroke, diabetes, kidney disease, and depression. The 
proportion of graduates that had more than two comorbidities (29.7%) was 
significantly less than the proportion that did not graduate (38.1%). 
Comparison of Graduation Status and Referral Indication  
A chi-squared test revealed no significant association between graduation 
status and referral indication (MI, PCI/stent, MI/PCI, CABG, valve 
replacement/repair, CABG/valve replacement/repair, heart transplant, stable 
angina, heart failure, other), χ2(9) = 6.865, p = 0.651.  
Table 13: Participant Factors and Graduation Status   




(n = 942) 
Not 
Graduated  
(n = 321) 
P Value 




Sex (n; % within graduation status) 
  
1.00 
Women 274 (29.1%) 94 (29.3%) 
 
Men 668 (70.9%) 227 (70.7%) 
 
Race (n; % within graduation status) 
  
0.958 
Caucasian 778 (82.6%) 264 (82.2%) 
 
African American 63 (6.7%) 23 (7.2%) 
 
Other 101 (10.7%) 34 (10.6%) 
 
Education‡ (n; % within graduation status) 
  
< 0.0005* 
University† 517 (54.9%) 116 (36.3%) 
 
College/Post-Secondary† 258 (27.4%) 118 (36.9%) 
 
High School or Less† 119 (12.6%) 68 (21.3%) 
 
Unknown 47 (5.0%) 18 (5.6%) 
 




Active 428 (45.4%) 146 (45.5%) 
 
Retired† 401 (42.6%) 108 (33.6%) 
 
Unemployed 29 (3.1%) 11 (3.4%) 
 
Medically Disabled† 46 (4.9%) 37 (11.5%) 
 
Unknown 38 (4.0%) 19 (5.9%) 
 
Comorbidities§ (n; % within graduation status) 
 
0.035* 
No Comorbidity 172 (18.4%) 49 (15.4%) 
 
1 Comorbidity 225 (24.0%) 62 (19.5%) 
 
2 Comorbidities 262 (28.0%) 86 (27.0%) 
 
>2 Comorbidities† 278 (29.7%) 121 (38.1%) 
 




PCI/Stent 222 (23.6%) 89 (27.7%) 
 
MI 201 (21.3%) 70 (21.8%) 
 
Valve Replacement/Repair 157 (16.7%) 50 (15.6%) 
 
CABG 147 (15.6%) 38 (11.8%) 
 
MI/PCI 122 (13.0%) 35 (10.9%) 
 
Heart Failure 36 (3.8%) 14 (4.4%) 
 
CABG/Valve Replacement/Repair 20 (2.1%) 8 (2.5%) 
 
Stable Angina  18 (1.9%) 8 (2.5%) 
 
Heart Transplant 4 (0.4%) 1 (0.3%) 
 
Other 15 (1.6%) 8 (2.5%) 
 
*p ≤ 0.05 
†Significantly different column proportions 
‡Education had 2 system missing cases; therefore, n = 1261 for relative analysis 
§Comorbidities had 8 system missing cases; therefore, n = 1255 for relative analysis 
SD, standard deviation; PCI, percutaneous coronary intervention; MI, myocardial infarction; CABG, 




Comparison of Age and Occupation Status 
Since age was significantly different between graduates and non-
graduates, and occupation status had a significant association with graduation 
status (discussed above), a one-way ANOVA was conducted to determine if age 
differed based on occupation status. There were no identified system missing 
cases (N = 1265). Homogeneity of variances was violated as assessed by 
Levene's test for equality of variance (p = 0.002). Therefore, a Welch ANOVA was 
conducted and revealed that age was significantly different between different 
occupation status, Welch's F(4, 153.978) = 195.932, p < 0.0005. Participants were 
categorized into five groups: active (n = 574; 56.65 years ± 10.18), retired (n = 510; 
71.01 years ± 8.37), unemployed (n = 40; 56.55 years ± 7.75), medically disabled 
(n = 84; 53.77 years ± 9.36), and unknown (n = 57; 62.46 years ± 11.35). Games-
Howell post hoc analysis revealed that the differences in age between retired 
participants and that who were unknown (-8.56 years, 95% CI -12.903 to -4.208), 
active (-14.36 years, 95% CI -15.902 to -12.821), unemployed (-14.46 years, 95% 
CI -18.093 to -10.831), or medically disabled (-17.24 years, 95% CI -20.253 to -
14.223) were all statistically significant (p < 0.0005), with retired individuals being 
the oldest participants. 
Comparison of Age and Prevalence of Comorbidities  
Since age was significantly different between graduates and non-
graduates, and the prevalence of comorbidities had a significant association with 
graduation status (discussed above), a one-way ANOVA was conducted to 




identified system missing cases for comorbidities (N = 1257). A one-way ANOVA 
revealed that age was statistically significantly different between the groups with 
different frequencies of comorbidities, F(3,1253) = 8.657, p < 0.0005. Participants 
were categorized into four groups: greater than two comorbidities (n = 399; 64.28 
years ± 10.76), two comorbidities (n = 350; 63 years ± 11.65), one comorbidity (n 
= 287; 61.83 years ± 12.52) and no comorbidity (n = 221; 59.43 years ± 12.32). 
Tukey post hoc analysis revealed that the increase in age between greater than 
two comorbidities and no comorbidity groups (4.85 years, 95% CI 2.321 to 7.371) 
was statistically significant (p < 0.0005), indicating that participants with greater 
than two comorbidities were older. Similarly, the increase in age between greater 
than two comorbidities and one comorbidity groups (2.45 years, 95% CI 0.116 to 
4.777) was statistically significant (p = 0.035), indicating that participants with 
greater than two comorbidities were older. Additionally, the increase between two 
comorbidities and no comorbidity groups (3.57 years, 95% CI 0.983 to 6.157) was 
statistically significant (p = 0.002), indicating that participants with two 
comorbidities were older.  
Logistic Regression Model for Graduation Status 
There were 12 identified system missing cases among all included 
variables; therefore, N = 1253. A logistic regression was performed to determine 
the likelihood that participants graduated or did not graduate from the program with 
age, sex, race, education, occupation status, and comorbidities as predictors in 
the model. A test of the final model, including all six predictors, compared to the 




Nagelkerke R2 = 0.072. The model correctly classified 75.1% of cases. Age was 
significantly associated with graduation status, where a one unit (one year) 
increase in age was associated with a 1.6% increase in the likelihood of graduating 
(odds ratio [OR] 1.016, 95% CI 1.002 to 1.030, p = 0.027). Education was 
significantly associated with graduation status, were compared to university 
education, high school or less education (OR 0.435, 95% CI 0.297 to 0.637, p < 
0.0005) and college/post-secondary education (OR 0.518, 95% CI 0.380 to 0.707, 
p < 0.0005) decreased the likelihood of graduating by 56.5% and 48.2%, 
respectively. The predictor comorbidities were trending towards significance (p = 
0.067). The results for the logistic regression are presented in Table 14.  
Table 14: Predictors of Program Completion  
Predictor Odds Ratio (95% CI) P Value 
Age (years) 1.016 (1.002-1.030) 0.027* 
Sex (ref: men) 1.136 (0.847-1.525) 0.395 
Race (ref: Caucasian)  
 
0.579 
African American 1.319 (0.779-2.234) 0.303 
Other 0.982 (0.640-1.508) 0.935 
Education (ref: university) 
 
< 0.0005* 
High School or Less 0.435 (0.297-0.637) < 0.0005* 
College/Post-Secondary 0.518 (0.380-0.707) < 0.0005* 
Unknown 0.640 (0.335-1.222) 0.176 
Occupation Status (ref: active) 
 
0.106 
Retired 1.181 (0.823-1.693) 0.366 
Unemployed 1.211 (0.575-2.553) 0.614 
Medically Disabled 0.583 (0.351-0.969) 0.037 
Unknown 0.739 (0.384-1.419) 0.363 
Comorbidities (ref: >2 comorbidities) 
 
0.067 
No Comorbidity 1.502 (1.002-2.253) 0.049 
1 Comorbidity 1.553 (1.076-2.241) 0.019 
2 Comorbidity 1.332 (0.951-1.866) 0.095 
*p ≤ 0.05 





2.7 Discussion  
CAD is the leading cause of mortality worldwide.2 CR is a secondary 
prevention program known to improve clinical outcomes and HRQoL in patients 
with CAD.6 Despite this, CR is underutilized around the world, and a CR model or 
models that is/are most efficient for all cohorts of participants in varying locations 
has yet to be established.13,14 The global CR “process” from referral to program 
completion is fairly similar, yet the “granular” details are less uniform: program 
characteristics, database dictionaries (e.g., what information is collected from 
participants and when), and participant characteristics vary, additionally different 
participant-level and system-level barriers exist. Consequently, not all standard-of-
care quality indicators are being met. To provide the greatest level of care, achieve 
the best possible outcome, and lower participant- and system-level barriers, it is 
essential to create an ideal CR model (or models) that encourage attendance and 
completion while meeting all standard of care quality indicators. This study took an 
important first step toward creating such a model (or models). Key findings 
emerging from this study are summarized in Table 15. These important findings 





Table 15: Key Findings  
Objective 1: Program Characteristics Description 
• All sites may want to consider “pre-habilitation” programs for individuals who have not yet 
had a CVD event, but have CVD risk factors 
• All sites may want to implement cost-effective participation incentives 
• Michigan sites may want to consider adopting the “use as needed” format for telemetry; 
similar to Ontario sites 
• All sites may want to consider collecting more participant data during programming 
Objective 2: Common and Unique Database Variables 
• All sites may want to collect point and date of referral  
• All sites may want to collect previous participation in CR 
• All sites may want to collect signs and symptoms of a participant’s cardiac condition(s) and 
a detailed history of comorbidities  
• All sites may want to collect more informative data regarding dietary content and eating 
habits  
• All sites may want to collect the availability of exercise equipment at home and a gym 
membership  
• All sites may want to collect religion 
• All sites may want to collect the spoken language of participants 
• All sites may want to collect a participant’s desired occupation status  
• All sites may want to collect travel distance to CR 
• All sites may want to collect risk of falling questions 
• All sites may want to collect attendance for each core component  
• All sites may want to collect adherence issues for core components at graduation  
Objective 3: Michigan Site Data Analysis 
• Participants were predominantly Caucasian men with university education 
• Participants predominantly had more comorbidities and were not actively employed 
• Having less than university education decreased the likelihood of graduating  






2.7.1 Phase 1 – Program Characteristics and Database Variables 
In both Canadian and United States-based CR models, the following steps 
occur: 1) an individual with an eligible diagnosis or diagnoses is referred to early 
outpatient CR, 2) individuals are contacted by a CRP liaison to arrange an intake 
appointment and undergo an intake assessment of key variables relative to a 
medical history, demographic information and other influences on health that may 
pose as barriers to CR participation and completion, a physical evaluation, and an 
exercise stress test protocol (all variables are collected in a database guided by 
the database dictionary), 3) the individual then begins an individualized early 
outpatient CRP, 4) individuals graduate from the early outpatient CRP and at 
program completion are re-evaluated on key variables (and occasionally at other 
time-points during the program), 5) after completion (i.e., graduation) of the early 
outpatient CRP an individual may begin the maintenance phase, 6) in some early 
outpatient CRPs individuals are evaluated again during long-term follow up (either 
as part of or separate to a structured maintenance phase; also reflected in the 
database dictionary). 
The examination of the program characteristics and database variables for 
the four CR sites provided valuable insight into the granular details of all the 
previously mentioned steps. Moreover, the inclusion of two Ontario sites and two 
Michigan sites promoted within and between country comparisons of CR models. 
Objective 1: Program Characteristics Description  
As expected, similarities and differences were discovered between the 




sites from the same country, yet similarities were most prevalent when sites were 
located in the same country.  
Program Overview 
 
All CRPs operated under the auspice of a health care system and were 
accordingly affiliated with a hospital. The sites in Ontario received funding from the 
Ministry of Health (i.e., the Government) and participants did not have a program 
fee as this was covered by provincial health care funding. In Michigan, the 
programs received commercial or government insurance funding, and program 
fees and participant co-payments were dependent on the funding source.  
Recognizing that financial cost is a barrier to program participation and 
completion, exploring ways to reduce participant-level cost is important, 
particularly in the United States.13–15,23 The Million Hearts Cardiac Rehabilitation 
Collaborative in the United States (founded by the Centres for Medicare and 
Medicaid Services and the Centres for Disease Control and Prevention) is 
composed of a spectrum of individuals involved with CR deliverance (e.g., federal 
and private sector organizations, CR participants) with the common goal of 
preventing one million cardiovascular events within five years.13 This collaborative 
suggests that to reduce expenses for CR participants, negotiations with insurance 
companies could occur to minimize out-of-pocket participant expenses, and a 
charitable fund supported by previous graduates or other donors could be 
established to provide financial assistance to participants with high-copayments or 
no insurance.13,24–26 The complexity of devising plans to share health care costs is 




within the health care system.24,25 Investigation into smaller scale strategies to 
reduce financial barriers for participants is warranted.  
 As part of the program overview, the Ontario sites indicated that the average 
number of weekly onsite sessions was two with an overall program duration of six 
months, directly aligning with national guidelines.8 In the United States, program 
duration is typically examined in accordance with the number of sessions approved 
by insurance usually equating to 36 onsite sessions, and commonly occurring 
three times per week.7 The Michigan sites offered 2 to 3 weekly onsite sessions 
that spanned anywhere from 8 to 18 weeks, with the actual program duration 
typically correlated with the number of insurance approved sessions. Evidently, 
overall program duration was longer within the Ontario sites suggesting that the 
Michigan sites could make between country comparisons to determine the number 
of weekly onsite sessions and overall program length that produces the most 
favorable outcomes for participants. In the United States, the ideal prescription for 
insurance to cover would presumably be the minimal amount of sessions needed 
to achieve benefit, however, this reduction in program duration may appeal to 
participants (e.g., minimization of financial burden and time-commitment) as well.  
Eligibility for Referral 
In general, the findings of this study provided support for similar referral 
eligibility criteria on either side of the border.7,8,10,27 All sites accepted referrals for 
an array of diagnoses that aligned with mandated eligibility criteria put forth by the 
CR governing bodies in both Canada and the United States.7,8,10,27 However, one 




coronary syndrome (ACS) and not solely MI, despite ACS being eligible in both 
countries.7,8,10,27 This same site uniquely accepted implantable cardioverter-
defibrillators and pacemakers following Canadian guidelines, but also accepted 
cardiac arrhythmias, congenital heart disease, and cardiomyopathies, which were 
not indicated in national guidelines.8,28 In Ontario, provincial guidelines also cite 
“having (a) CVD risk factor(s) only (e.g., hypertension but with no CVD event)” as 
an accepted criterion for referral, yet neither site appeared to include this 
participant cohort.28 One of the sites in Michigan also veered from national 
guidelines by uniquely accepting left ventricular assist devices and peripheral 
arterial disease.7 An explanation for the deviation by these CR sites from the 
eligibility criteria proposed in guidelines could be that the national guidelines (e.g., 
CACPR and AACVPR) are outdated (i.e., not within the last 5 years) and as such, 
the benefit for other participant populations may have since been established 
(perhaps even within these individual CR sites), and thus updated endorsement 
and guidelines from governing bodies is required.7,8 Furthermore, research is 
warranted to better understand why sites in the same country and within the same 
province or state would not have identical eligibility criteria. Once within country 
nuances are justified, between country differences may be examined and the 
impact of CR on outcomes for cohorts of participants with varying referral 
indications can be established. 
Furthermore, although it is unclear why Ontario sites would not have CVD 
risk factor-only participants as part of the CR clientele, it could be speculated that 




early outpatient CRPs would be quickly surpassed if participants with only CVD 
risk factors and no CVD event were referred.3 As these “at risk” individuals would 
benefit from CR, they could still be identified at both the Ontario and Michigan sites 
and provided with resources to adopt beneficial lifestyle changes at home, such as 
improving dietary intake and physical activity. This programming could be 
considered “pre-habilitation” and insurance coverage, especially in the United 
States could be advocated. In fact, the CR model has been followed to provide 
lifestyle interventions to individuals with metabolic syndrome (a group of 
cardiometabolic risk factors including, but not limited to hypertension, glucose 
intolerance and high blood insulin levels, hyperlipidemia, and obesity) and has 
proven to produce positive outcomes by eliminating the prevalence of metabolic 
syndrome and the related CVD risk factors in individuals.29–31 Therefore, the 
chance of CVD and ultimately CAD is reduced.30,31  
Referral Details 
A variety of referral procedures were observed across the four sites and 
most often included both automatic and paper referrals depending on the point of 
referral. Sites had multiple points of referral, including acute care, inpatients at site-
affiliated hospitals, and outpatients at affiliated physician offices. Although beyond 
the scope of the current study, future work could explore these procedural 
variations and determine those that elicit maximal referral rates. Consideration of 
the different health care systems and the related points of referral at each site may 
also be crucial as deviations of automatic referral could be more beneficial in 





None of the sites offered participation incentives, but all may want to 
consider implementing incentives as a strategy to increase rates of program 
attendance and completion.13,32 The benefit of this was demonstrated when a CRP 
at the Mayo Clinic (Rochester, Minnesota, United States) implemented a 
motivational program which included participants receiving specific prizes (e.g., 
parking pass, T-shirt, tote bag) after every sixth session attended, and staff 
members receiving similar prizes for promoting participant success.32 The median 
number of sessions attended increased by three.32 The sites in this study could 
design cost-effective incentive programs for their cohorts of participants and test 
their effectiveness. 
Exercise Training Details 
In the current study, all sites conducted an exercise test to guide exercise-
related programming at intake. However, one of the Michigan sites conducted 
exercise tests on only 50% of participants. Three of the sites measured maximal 
VO2, whereas one of the sites estimated this measurement with submaximal 
exercise testing protocols. The utilization of exercise testing could be discussed 
among the sites to understand individual rationales for exercise testing and discuss 
the merits and disadvantages of existing procedures in CR populations.  
ECG-monitoring or telemetry use during exercise occurred across the sites 
in Michigan, but not in Ontario. One Michigan site indicated its use for the first three 
exercise sessions then discontinuation until clinical need, whereas the other 




and in the absence of signs and/or symptoms. The slight nuance between the 
Michigan sites warrants further examination. It may be worthwhile for the Michigan 
sites to consider following the “use as needed” format as per the Ontario-based 
sites. This change would require approval from insurance providers, but it may 
reduce programming costs and lessen participant burden. 
Data Collection Time-Points 
All sites collected data at intake and graduation. Three of the sites collected 
data from participants at different time points during CR programming, yet only one 
of these sites (an Ontario site) collected data that mirrored intake. This 
comprehensive assessment was only conducted when warranted. All sites may 
want to consider collecting data during programming to determine if individualized 
programs need to be adjusted throughout the duration of early outpatient CR 
participation to maximize adherence and benefit. 
One of the Michigan sites collected data from participants at multiple time 
points following graduation (1, 6, and 12 months after graduation, then following 
every 6 months thereafter), delivering an assessment similar to that at intake. The 
other sites may want to adopt such follow-up procedures, as these align with 
national guidelines, and provide valuable information on the maintenance of 
benefits.7 As implementation of lifestyle changes diminishes within 3 to 6 months 
following early outpatient CR, this may provide insight into the challenges 
experienced by graduates and provide a platform to create strategies for 
improvement from both a provider and participant perspective.7 Additionally, post-




based programming for participants following graduation as part of the 
maintenance phase. 
Staff Members 
All sites had a medical director who is a physician. However, there was 
variation in the designation of the program director, as well as the number of and 
amount of participant interaction with exercise physiologists/kinesiologists, 
dietitians, and nurses. These differences may be attributed to the funding that the 
programs receive or the capacity the programs have for participants but could 
nonetheless be a point of discussion between the sites to determine an ideal 
participant to staff ratio. One site had a psychologist, whereas the other three sites 
did not, and as such, an appointment with a psychologist is typically provided 
following a referral. Considering that psychological and social factors (e.g., 
depression, anxiety, stress) are modifiable CVD risk factors that can negatively 
impact disease progression following a cardiac event, perhaps all sites could 
consider having a psychologist on staff to eliminate the wait time of referrals.33,34 
However, two of the sites without a psychologist did have a social 
worker/behaviourist/stress management personnel on staff and the other site 
referred participants to these services so this may also assist with psychosocial 
management. It is important to recognize that these specialties require substantial 
monetary support and may thus not be feasible. 
Home-Based Programming 
Three of the four sites offered home-based programming to participants, yet 




one of the Michigan-based sites involved live two-way audio and video 
conferencing and online presentations for delivery of core components. Thus, 
home-programming is yet another area where the sites could converse about 
implemented methods. Future work could investigate the strengths and 
weaknesses of these protocols as predictors of participant success, while 
ascertaining the associated cost implications. 
Objective 2: Common and Unique Database Variables  
 Numerous common and unique variables were identified in the database 
variables collected across the four sites. 
Variables Collected at Intake 
Referral and General Intake  
 Only the Ontario sites collected the point of referral. As referral rates are 
suboptimal in Canada and the United States, the Michigan-based sites may benefit 
from collecting this information, with future research exploring the potential 
shortcomings of specific referral locations (e.g., inpatient unit, cardiac 
diagnostics/intervention unit, physician office).13,14 Similarly, only the Ontario sites 
collected date of referral. This is important information for calculating governing-
body benchmarks for post-discharge CR enrollment (i.e., Canada - 30 days, United 
States - 21 days) and something for all sites to consider collecting.9,10 Strategies 
for maximizing referral and achieving mandated benchmarks at all sites could then 
be designed, implemented and investigated. Moreover, a unique variable collected 




be of interest to the other sites as well, and future work could determine its impact 
on program attendance and completion, as well as clinical outcomes. 
Medical History 
The database dictionaries varied across the sites in the extent that medical 
history related variables were collected at intake, ranging from “essential only” to 
“very comprehensive”. All sites collected the event or indication for referral to early 
outpatient CR, which is valuable for determining if participants with specific 
diagnoses (e.g., CABG) are more likely to participate than others in the modern 
era of CR, where CR utilization is endorsed in both countries for an array of 
diagnoses.16–18 All sites also collected the diagnoses of hypertension and diabetes, 
and prescribed medications. A unique variable collected by one of the Michigan-
based sites was the signs and symptoms of a participant’s cardiac condition(s). 
This could be beneficial for all sites to collect as an indication of secondary events 
that may occur during the exercise training component of CR (that is if approval 
for exercise training is granted following the intake assessment). The same 
Michigan site uniquely collected gynecological, family, and an extensive 
comorbidity history, the latter of which could be beneficial for all sites to collect in 
effort to identify and overcome barriers to CR participation and completion (please 
see page 130 for additional discussion).   
There were no common variables identified among the sites to evaluate the 
dietary content and eating habits of participants. One Michigan site collected 
information regarding what the participant considered a healthy weight to be for 




counselling, and motivation, confidence and obstacles to improving dietary intake. 
These variables provide value and insight into the anthropometrical measurement 
of weight, rather than simply collecting an objective number. Furthermore, 
collection of dietary content and eating habits may be useful when referring 
participants to nutritional counselling and weight management programs. 
Considering these are core components of early outpatient CR in both countries, 
all sites may want to collect these variables.7,8  
There was inconsistency in how emotional and psychosocial health was 
assessed across the sites. Overall, different assessments were employed for 
depression and anxiety, with little focus on stress. Future studies could examine 
the most efficient method of assessment. 
Once again, there is variation in how relative variables for physical activity 
or exercise patterns are collected. Due to their broad nature, recommending 
specifics on what habitual exercise-related data should be collected across sites 
is beyond the scope of this study, and warrants further collaborative investigation 
by the sites. Having said that, a unique set of variables collected at one of the 
Michigan sites is worth considering for immediate collection across all sites: 
“exercise equipment at home” and “membership to a gym”. This information may 
inform off-site exercise training options, which is especially important in an era 
where hybrid and home-based CR programming is gaining endorsement.35–37 
Three sites (the Ontario sites and one Michigan site) collected variables at 
intake reflective of alcohol consumption, however a unique variable collected by a 




Identifying current status of consumption and quantifying motivation to change 
guides referrals and subsequent CR-related programming, including psychological 
and/or nutritional counselling and goal-setting, all representing vital aspects of 
early outpatient CR.7,8  
Current tobacco smoking status was collected by all sites in the study, 
although there was variation in the variables collected across the sites in relation 
to details of tobacco use. Future work could aim to determine which of these 
assorted variables, if any, predicts success of smoking cessation. This would 
streamline data collection and may guide the delivery of tobacco cessation 
services.  
Demographic Information and Barriers to CR Participation and 
Completion 
All sites collected a variation of demographic information. When collecting 
sex, some sites use the term sex interchangeably with gender. In the modern era 
of gender identification, a distinction between the two terms should be made to be 
inclusive to all participants. Future studies could examine specific barriers to CR 
participation and completion that participants with different gender identities may 
experience and/or the potential for increased risk of CVD progression (i.e., novel 
findings have suggested that hormone therapy may proliferate CVD risk factors).38 
The Muslim religion has previously been identified as a potential barrier that 
prevents women from participating in CR, yet only one site (a Michigan-based site) 
collected participants’ religions.17,39 Moving forward, the influence of other religions 




participation and completion can be employed (e.g., women-only exercise training 
classes, sex and/or religion-exclusive social support by CR staff members).7,13 
Linguistic abilities for non-English native speakers have been identified as 
a barrier to CR participation and completion.19,21 The Ontario sites collected this 
information, but it may be helpful for the Michigan sites to collect spoken language 
of participants as well. Suggested strategies to overcome this barrier to 
participation and completion could then be explored, such as providing 
supplemental written material in varying languages, having interpreter services, or 
having bilingual staff members.7,8 It would, however, be important to determine the 
cost-benefit ratio of these interventions.  
It is promising that three sites (two Ontario sites and a Michigan site) 
collected information on education and occupation, as these are known barriers to 
CR participation and completion.15,17,18 A unique variable collected by the Ontario 
sites was the participant’s desired occupation status. Goal-setting is a major 
aspect of early outpatient CR in both Canada and the United States, and thus the 
collection of a participant’s desired occupation status by all sites would be 
beneficial. Not only would attainment of desired occupation status provide insight 
into whether returning to work is a participant’s priority and adjust programming 
accordingly (e.g., offer vocational counselling), it could also serve as a goal to 
promote CR attendance by emphasizing that CR participation can increase the 
rate of returning to work.7,8 While one Michigan site collected participants’ 
insurance information, all sites could consider collecting a variable more relevant 




to identify participants who may experience financial burdens that impede CR 
participation and completion and then employ strategies to help combat financial 
barriers. This is especially important for the Michigan sites, where early outpatient 
CR is not entirely covered by funding sources like it is for the sites in Ontario. 
Three of the sites (Ontario sites and one Michigan site) collected living 
situation and marital status, while the Michigan-based sites collected additional 
social support information. Moving forward, all sites may want to obtain collective 
social support information, which could be used in a future study to determine 
predictors of program completion concomitant to the efficacy of strategies (e.g., 
buddy system, carpooling) designed to increase social support.7  
It is promising that the Ontario sites collected travel distance information at 
intake. By doing so, increased travel distance as a barrier to participation and 
completion can be identified immediately, and strategies (e.g., hybrid or home-
based programming) implemented to promote participant success.35–37 Thus, it 
would be worthwhile for all sites to consider collecting travel distance and/or travel 
time to CR sites. 
Physical Evaluation  
All sites collected vital signs and anthropometric data in a similar manner, 
yet there was variation in how physical status was assessed. It is unclear if these 
differences are meaningful, and it is recommended that expert analysis be 
conducted to determine the most suitable and efficient variables to collect. A key 




collected by one Ontario site. Risk of falling is an important safety factor and may 
be something all sites may want to collect at intake.  
Exercise Test 
There were many similar variables collected by the sites with respect to the 
exercise test. Three of the sites (two Ontario sites and a Michigan site) collected 
the reason for termination. This information may provide a platform for future 
research studies investigating common causes of exercise test termination, and 
guide future “accommodated” CR programming. A unique variable collected by a 
Michigan site was the 6-minute hall walk score. This may be an important testing 
consideration for the other sites, at it could be a viable economical option to use 
for participants who have limiting factors that prevent completion of maximal and 
submaximal exercise tests, but still require an individualized exercise training 
programming.7,8,28 
Questionnaires  
Sites used varying questionnaires to collect information on overall health, 
psychological health, physical health, and nutrition. A modern standardized 
questionnaire or a battery of questionnaires for CR participants could be fostered 
using expertise from across the sites.  
Staff Members 
Three sites (two Ontario sites and a Michigan site) noted the assigned 
participant case manager. This is something to consider for all sites, as 





Variables Collected During Programming  
Attendance  
All sites in the current study collected attendance data, although the format 
differed. For example, the Ontario sites collected attendance rates for specific core 
program components, whereas the Michigan sites generalized by collecting the 
total number of sessions attended. It may be beneficial for all sites to collect 
attendance information across the components and use this information during in-
program evaluation sessions to potentially intervene and employ strategies to 
increase attendance for all core components.  
Variables Collected at Graduation  
The only identical variable collected across sites was an exit exercise test. 
One Ontario site and one Michigan site administered graduation assessments that 
almost mirrored intake assessment procedures and is something all sites may 
want to consider to best evaluate both participant and program success. Similar to 
intake, sites collected varying questionnaires on overall health, psychological 
health, physical health, and nutrition. Once again, a modern standardized 
questionnaire or a battery of questionnaires could be created. A program 
evaluation was also administered by one of the Michigan sites, and may be 
considered useful by the other sites to evaluate the program quality from a 
participant perspective. 
One Michigan site collected if participants are having trouble adhering to 
the components of CR (e.g., taking prescribed medication, getting regular 




can be made to help the participant better address personal needs and discharge 
the participant with the appropriate tools for transition into a less-interactive 
maintenance program, or independent management of health behaviours.7,8 Three 
sites (two Ontario sites and a Michigan site) collected the reason a participant 
graduated or ceased to attend CR (e.g., completed program, insurance, return to 
work). As completion rates in Canada and the United States are suboptimal, 
collecting this information on why participants are not completing CR is worthwhile. 
2.7.2 Phase 2 – Michigan Site Data Analysis  
As previously mentioned, the benefits of CR are well-known, yet 
participation and completion rates for CR are suboptimal.6,13,14 To date, evidence 
suggests that older participants, women, minorities, those with a lower 
socioeconomic status (i.e., lower education, unemployed, lower income), 
participants having numerous comorbidities, and participants referred for an 
indication other than CABG are less likely to participate in and/or complete CR.15–
20,22 Subsequent strategies to overcome these barriers have been suggested13,19, 
but future research work is warranted for multiple reasons: 1) there is still a need 
to improve participation and completion rates, and 2) available evidence provides 
conflicting results, was minimally studied and/or was performed in an older era of 
CR programming.  
Phase 2 of this study was a first step in addressing these gaps in the 
literature. Specifically, this study characterized a participant cohort in a modern era 




Region, and identified participant factors that impacted graduation (i.e., program 
completion).  
As expected, participants were predominantly Caucasian, and were highly 
educated men, yet were older in age, had a greater prevalence of comorbidities, 
were not actively employed, and PCI or stent was the primary indication for referral. 
Significant predictors of program completion were age and education. Findings are 
discussed in detail below. It is important to note that this early work is reflective of 
United States-based programming and may not be generalizable to Canadian-
based programs, despite close geographical proximity in our Great Lakes Central 
Region. 
Characterization of the Population 
In alignment with previous studies, the participants in this study were 
predominantly Caucasian men with higher education (e.g., university).15–17,21,22 
Therefore, implementation of strategies to encourage participation of racial 
minorities, women, and those with lower levels of education is warranted for this 
early outpatient CRP. Contrary to the hypothesis and to previous work, the current 
population was on average older, with more comorbidities, not actively employed, 
and referred for PCI or stent.15–18 Future research could assess the tactics used 
within this CRP that endorsed participation of older participants and those with 
more comorbidities and then apply these strategies to other CRPs. Moreover, 
strategies to encourage younger participants and those with fewer comorbidities 




the participation for different referral indications and actively employed participants 
could be explored as well.  
Participant Factors and Program Completion  
Age  
When examining the logistic regression model, each yearly increase in age 
was associated with a slight 1.6% increase in the likelihood of graduating.  
Previous research has presented older age as a barrier to participation and 
completion, but the effect of age may actually be more fluid in regard to CR 
participation and completion.15–18 For instance, a recent systematic review of the 
factors associated with non-participation in, and dropout from, CRPs showed 
contrasting results.17 In essence, drop-out rates varied in the studies examined, 
increasing for both older and younger participants.17 Additionally, a recent study in 
the United States that utilized data from the Behavioral Risk Factor Surveillance 
System (Centres for Disease Control and Prevention; 2005 to 2015) concluded 
that participation in CR was more likely for participants who were 65 years of age 
or greater compared to younger participants who were 18 to 54 years of age (OR 
1.787, 95% CI 1.540 to 2.074, p < 0.0001).40  
Despite the findings from this study representing age only modestly 
increasing the likelihood of graduating in the logistic regression model, the 
prevalence of older participants completing the program may be explained by the 
greater time availability they experience, especially as they approach and enter 
retirement. As speculated, it was determined that the retired participants were 




the previously mentioned Behavioral Risk Factor Surveillance System study 
concluded that retired or self-employed participants were more likely to participate 
in an early outpatient CRP, perhaps due to schedule flexibility.40 
Therefore, it is important that younger participants, especially those who 
have more time commitments (e.g., employment obligations) are identified during 
the intake assessment, and that accommodations are made for the participants’ 
schedules, such as implementing and prescribing hybrid or home-based 
programming to encourage participation and completion.35–37 However, this 
Michigan site does not offer these alternative forms of CR programming and may 
want to discuss with the other Michigan site how to deliver programming and 
overcome the associated cost implications for participants in the United States.37 
The site could also consider adopting an adaptable on-site program schedule 
incorporating early morning, after work, or weekend hours to accommodate a 
participant’s commitments; that is if the addition of hours of operation does not 
pose a financial burden on the CRP.13 
Education  
The logistic regression model also revealed that compared to holding a 
university education, high school or less education and college/post-secondary 
education decreased the likelihood of graduating by 56.5% and 48.2%, 
respectively. These findings align with previous research that suggested 





The first possible explanation for these findings is that with higher 
education, individuals secure higher paying jobs, leading to financial and 
retirement stability.41,42 Therefore, participants with higher education do not 
experience the financial barrier to completing CR as they have the monetary funds 
to override non-universal healthcare coverage in the United States and to 
participate even when retired.41,43 
Secondly, the skills obtained from pursuing higher education (e.g., critical 
thinking, problem solving, perseverance) are viewed as transferable to taking care 
of one’s health.42,44 Therefore, in relation to the current study, graduates may 
possess this perception of power to control one’s health.42,44 
The intake assessment is crucial in identifying participants who have a lower 
education; therefore, education should continue to be collected in the site’s 
database. If a participant is lacking the skills to feel in control of one’s health, extra 
time can be spent educating the participant on CVD risk factor management and 
self-care, and goal-setting can be used to provide the perception of power and 
control.7,8 
Occupational Status 
  While more weight should be given to the results of the multivariate 
analysis, the findings of the univariate analysis for occupation status and 
graduation status are still important to discuss. In this CR cohort, there was a 
significantly higher proportion of participants graduating who were retired 
compared to non-graduates. These findings are in contrast to the majority of 




likely to participate.15,18 As such for this cohort of participants, similar strategies as 
those proposed for younger participants (e.g., home-based programming, 
adaptable on-site program schedules) could be used to promote program 
completion for participants who are not retired, as time-availability is the suspected 
barrier to participation and completion.13,35–37 
 A significantly lower proportion of participants who were medically disabled 
graduated compared to those who did not graduate. Despite the low prevalence of  
participants who are medically disabled in this cohort, this statistically significant 
finding is still worth mentioning because program completion should be maximized 
for all participants. As such, these findings align with the majority of previous 
research that suggested individuals who are employed are more likely to 
participate.15,18 The definition for disability presented by the United States 
Government in regards to the benefits provided for individuals with disabilities is: 
“the inability to engage in any substantial gainful activity by reason of any medically 
determinable physical or mental impairment(s) which can be expected to result in 
death or which has lasted or can be expected to last for a continuous period of not 
less than 12 months.”45 Evidently, if a participant has difficulty completing activities 
and is very low functioning, transportation to CR and program attendance will be 
a burden. Additionally, while participants could be receiving financial support (e.g., 
Social Security, Medicaid, Medicare), the participants are still unemployed so the 
financial burden of participating in CR could impact completion as well.15,23 
The strategies suggested for encouraging program completion of 




be applied to improve completion of participants identified as medically disabled, 
such as home-based programming if the participants are homebound.13,35–37  
Comorbidities  
Notably, comorbidities were trending towards significance as a predictor 
variable in the logistic regression. As the data suggested, the proportion of 
graduates that had more than two comorbidities was significantly less than the 
proportion that did not graduate. These findings align with recent reviews of CR, 
and it has been suggested that higher rates of comorbidities (e.g., depression, 
stroke, COPD) are related to early drop-out from CR.15,17,46 
Unmistakably, CR is modeled to manage CVD risk factors, however the 
basis of the model can improve the status of the majority of chronic diseases.47 
Therefore, it is important that a participant with multiple comorbidities is 
encouraged to stay in CR to learn how to manage one’s health and better one’s 
overall HRQoL.48 Conclusively, comorbidities (i.e., chronic diseases) cannot be 
treated independently and thus this site should strive to apply the rehabilitation 
aspect of CR to all chronic diseases, not solely CVDs. With that said, the intake 
assessment is once again vital in flagging participants with a high prevalence of 
comorbidities at intake. Notably, this Michigan site collects an extensive list of 
comorbidities and should continue this practice.  
It is also important to evaluate at intake how CR could be viewed as an 
inconvenience for the participant, adding to the participant’s perceived disease 
burden. This emphasizes the importance of individualized programs in CR so 




heard and accounted for with respect to the delivery of care. Another way to reduce 
the burden for participants is to ensure coordinated care. It is important that CR 
staff members are in communication with other health care providers that are part 
of the participant’s overall care plan to provide maximum standard of care 
treatment.49 Furthermore, if participants are homebound, perceived burden could 
also be reduced by offering adapted or usual home-based programming to 
minimize transportation or accessibility issues.13,35,37 Once again, this Michigan 
site may want to discuss the logistics of alternative programming with the other 
Michigan site.  
A statistically significant difference was also observed between age and the 
number of comorbidities, suggesting that older participants have more 
comorbidities. It is predictable that older aged participants are diagnosed with more 
comorbidities, but what is unexplained is the opposite effect that age and 
comorbidities have on graduation status, despite participants with greater than two 
comorbidities being the oldest aged cohort in this study. It is possible that the 
numerous burdens of having multiple comorbidities outweigh the benefit of time 
availability acquired with retirement. With multiple comorbidities and the 
accumulated impairments, along with the prescription of numerous medications 
and the potential negative interactions of medications, participants likely feel 
overwhelmed and burdened.50 Having more comorbidities will ultimately reduce a 
participant’s functionality and increase frailty, which are important aspects to 






 In contrast, sex did not have a significant association with graduation status. 
This is surprising as it is established in the literature that women are less likely to 
participate and complete programming.15–20 Despite the non-significant findings 
between sex and graduation status, when further examining this cohort of 
participants, there are over two times as many men compared to women. With this 
said, once women enroll in this early outpatient CRP, they may have the same 
probability as men to complete (e.g., within each sex approximately three quarters 
of participants completed programming). Therefore, the barriers for women to 
complete this program could potentially arise during the referral process and 
enrollment stage. There have been numerous barriers suggested that prevent 
women from being referred to and enrolling in early outpatient CR, such as lack of 
physician endorsement, misconceptions of exercise and CR, and family 
obligations.19 However, it is important to identify barriers for this specific cohort of 
participants and the impact of local factors to develop equal representation of men 
and women within this program.19 
Race 
 Furthermore, race was not significantly associated with graduation status. 
Previous research has suggested that Caucasians  are more likely to participate, 
whereas individuals identifying as a minority prevents participation and/or program 
completion.16,21,22 Due to race not having an impact on program completion, 
characteristics of this early outpatient CRP that promote participation and 




other sites that may experience race as a barrier. However, it should be noted that 
this cohort of participants was predominantly Caucasian, as discussed earlier, 
which could be explained by the location of this site (i.e., the majority of the residing 
population is Caucasian). Therefore, the low representation of races other than 
Caucasian in this early outpatient CRP may be simply a result of participants who 
are another race not residing in the vicinity of the program, and unlike sex, it is not 
due to the cohort of participants being uncommonly referred or enrolled to this 
CRP. 
 Referral Indication  
 In contrast to previous research that suggested participants who had CABG 
were more likely to participate and/or complete programming, referral indication 
was not associated with graduation status.17,18 These findings indicate that this 
early outpatient CRP may decide to focus its energy on overcoming other barriers 
to participation and completion of programming. Moreover, if this program 
implements specific strategies to foster the participation and completion of all 
eligible diagnoses then this information should be further investigated and broadly 
shared with other sites with similar participant cohorts and program characteristics. 
2.8 Conclusion 
This study took an important first step toward establishing a CR model or 
models that is/are most efficient for all cohorts of participants in varying Ontario 
and Michigan based sites. Through examination of the “granular” details of each 
site it was determined that all sites may want to consider implementing specific 




programs for individuals at risk of developing CVD and participation incentives for 
those completing early outpatient CR. Moreover, differences between the sites 
(e.g., the use of telemetry) warrant further investigation. While changes in program 
characteristics should ultimately be adopted to benefit participants, the cost 
implications of all program changes need to be considered to minimize financial 
burden, especially for Michigan sites. As such, the expertise from all sites should 
be leveraged to develop strategies that not only provide participant benefit, but 
also cost-efficient solutions.  
Nonetheless, strategies may also need to be specific to certain cohorts of 
participants, especially those that may have factors that hinder their CR 
participation and completion. Therefore, while all sites collected vital information in 
their databases regarding participants, certain differences emerged suggesting 
that all sites may want to collect aspects such as a participant’s: status of previous 
CR participation, extensive comorbidity history, religion, spoken language, desired 
occupation status, travel distance, availability of exercise equipment at home or 
membership to a gym, and adherence issues with CR components. Additionally, 
all sites may want to also consider the importance of collecting all-encompassing 
participant data not only at intake and program completion, but during 
programming as well.  
Through collection of participant information, factors that impede program 
completion may be better understood. Using historical participant data from one 
site, the current study shed light on characteristics of their participant cohort that 




of conducting a larger scale study with data from all sites. This would not only allow 
for within site exploration, but it would foster the ability to examine regional 
similarities and differences in CR populations.  
It became clear that increasing age and obtaining higher education were 
associated with program completion in this cohort, with age only modestly 
increasing the likelihood of completing programming. Overall, not all factors in the 
logistic regression model were associated with graduation status, therefore other 
factors need to be explored (e.g., annual income, insurance coverage, 
transportation, travel distance, time-availability, social support). Since sex and 
race were not associated with program completion, these findings may suggest 
that the site is appropriately providing resources to women and participants who 
identify as minorities to complete programming.  
Overall, this research laid the foundation for within and between country 
comparisons across the four involved sites and can lead preliminary discussions 
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Graduation Status Gender Education Occupation Status Comorbidities Referral Indication Race
Valid 1263 1265 1263 1265 1257 1265 1265












N Mean Std. Deviation Std. Error Mean
Not Graduated 321 60.4704 12.44261 0.69448





Equal variances assumed 0.987 0.321 -3.599 1261 0.000 -2.73554 0.76018 -4.22690 -1.24418
Equal variances not assumed -3.465 519.250 0.001 -2.73554 0.78945 -4.28644 -1.18464
Age
Independent Samples Test
Levene's Test for Equality of Variances t-test for Equality of Means
F Sig. t df Sig. (2-tailed) Mean Difference
Std. Error 
Difference













N Percent N Percent N Percent





Count 227a 668a 895
Expected Count 227.5 667.5 895.0
% within Sex 25.4% 74.6% 100.0%
% within Graduation Status 70.7% 70.9% 70.9%
% of Total 18.0% 52.9% 70.9%
Standardized Residual 0.0 0.0
Count 94a 274a 368
Expected Count 93.5 274.5 368.0
% within Sex 25.5% 74.5% 100.0%
% within Graduation Status 29.3% 29.1% 29.1%
% of Total 7.4% 21.7% 29.1%
Standardized Residual 0.0 0.0
Count 321 942 1263
Expected Count 321.0 942.0 1263.0
% within Sex 25.4% 74.6% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.4% 74.6% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.













Pearson Chi-Square .004a 1 0.947 1.000 0.500
Continuity Correctionb 0.000 1 1.000
Likelihood Ratio 0.004 1 0.947 1.000 0.500
Fisher's Exact Test 0.943 0.500
Linear-by-Linear Association .004c 1 0.947 1.000 0.500 0.056
N of Valid Cases 1263
b. Computed only for a 2x2 table
c. The standardized statistic is -.067.
Chi-Square Tests












N Percent N Percent N Percent





Count 264a 778a 1042
Expected Count 264.8 777.2 1042.0
% within Race 25.3% 74.7% 100.0%
% within Graduation Status 82.2% 82.6% 82.5%
% of Total 20.9% 61.6% 82.5%
Standardized Residual -0.1 0.0
Count 23a 63a 86
Expected Count 21.9 64.1 86.0
% within Race 26.7% 73.3% 100.0%
% within Graduation Status 7.2% 6.7% 6.8%
% of Total 1.8% 5.0% 6.8%
Standardized Residual 0.2 -0.1
Count 34a 101a 135
Expected Count 34.3 100.7 135.0
% within Race 25.2% 74.8% 100.0%
% within Graduation Status 10.6% 10.7% 10.7%
% of Total 2.7% 8.0% 10.7%
Standardized Residual -0.1 0.0
Count 321 942 1263
Expected Count 321.0 942.0 1263.0
% within Race 25.4% 74.6% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.4% 74.6% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.














Pearson Chi-Square .087a 2 0.957 0.958
Likelihood Ratio 0.086 2 0.958 0.958
Fisher's Exact Test 0.125 0.950
Linear-by-Linear Association .003b 1 0.958 0.960 0.495 0.040
N of Valid Cases 1263
b. The standardized statistic is -.052.
Chi-Square Tests









N Percent N Percent N Percent





Count 116a 517b 633
Expected Count 160.6 472.4 633.0
% within Education 18.3% 81.7% 100.0%
% within Graduation Status 36.3% 54.9% 50.2%
% of Total 9.2% 41.0% 50.2%
Standardized Residual -3.5 2.1
Count 68a 119b 187
Expected Count 47.5 139.5 187.0
% within Education 36.4% 63.6% 100.0%
% within Graduation Status 21.3% 12.6% 14.8%
% of Total 5.4% 9.4% 14.8%
Standardized Residual 3.0 -1.7
Count 118a 258b 376
Expected Count 95.4 280.6 376.0
% within Education 31.4% 68.6% 100.0%
% within Graduation Status 36.9% 27.4% 29.8%
% of Total 9.4% 20.5% 29.8%
Standardized Residual 2.3 -1.3
Count 18a 47a 65
Expected Count 16.5 48.5 65.0
% within Education 27.7% 72.3% 100.0%
% within Graduation Status 5.6% 5.0% 5.2%
% of Total 1.4% 3.7% 5.2%
Standardized Residual 0.4 -0.2
Count 320 941 1261
Expected Count 320.0 941.0 1261.0
% within Education 25.4% 74.6% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.4% 74.6% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.





















Pearson Chi-Square 35.887a 3 0.000 0.000
Likelihood Ratio 35.869 3 0.000 0.000
Fisher's Exact Test 36.034 0.000
Linear-by-Linear Association 20.716b 1 0.000 0.000 0.000 0.000
N of Valid Cases 1261
b. The standardized statistic is -4.552.
Chi-Square Tests









N Percent N Percent N Percent
Occupation Status * 
Graduation Status





Count 146a 428a 574
Expected Count 145.9 428.1 574.0
% within Occupation Status 25.4% 74.6% 100.0%
% within Graduation Status 45.5% 45.4% 45.4%
% of Total 11.6% 33.9% 45.4%
Standardized Residual 0.0 0.0
Count 108a 401b 509
Expected Count 129.4 379.6 509.0
% within Occupation Status 21.2% 78.8% 100.0%
% within Graduation Status 33.6% 42.6% 40.3%
% of Total 8.6% 31.7% 40.3%
Standardized Residual -1.9 1.1
Count 11a 29a 40
Expected Count 10.2 29.8 40.0
% within Occupation Status 27.5% 72.5% 100.0%
% within Graduation Status 3.4% 3.1% 3.2%
% of Total 0.9% 2.3% 3.2%
Standardized Residual 0.3 -0.2
Count 37a 46b 83
Expected Count 21.1 61.9 83.0
% within Occupation Status 44.6% 55.4% 100.0%
% within Graduation Status 11.5% 4.9% 6.6%
% of Total 2.9% 3.6% 6.6%
Standardized Residual 3.5 -2.0
Count 19a 38a 57
Expected Count 14.5 42.5 57.0
% within Occupation Status 33.3% 66.7% 100.0%
% within Graduation Status 5.9% 4.0% 4.5%
% of Total 1.5% 3.0% 4.5%
Standardized Residual 1.2 -0.7
Count 321 942 1263
Expected Count 321.0 942.0 1263.0
% within Occupation Status 25.4% 74.6% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.4% 74.6% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.























Pearson Chi-Square 22.786a 4 0.000 0.000
Likelihood Ratio 21.047 4 0.000 0.000
Fisher's Exact Test 21.431 0.000
Linear-by-Linear Association 7.320b 1 0.007 0.007 0.004 0.001
N of Valid Cases 1263
b. The standardized statistic is -2.705.
Chi-Square Tests









N Percent N Percent N Percent
Comorbidities * Graduation 
Status





Count 121a 278b 399
Expected Count 101.1 297.9 399.0
% within Comorbidities 30.3% 69.7% 100.0%
% within Graduation Status 38.1% 29.7% 31.8%
% of Total 9.6% 22.2% 31.8%
Standardized Residual 2.0 -1.2
Count 49a 172a 221
Expected Count 56.0 165.0 221.0
% within Comorbidities 22.2% 77.8% 100.0%
% within Graduation Status 15.4% 18.4% 17.6%
% of Total 3.9% 13.7% 17.6%
Standardized Residual -0.9 0.5
Count 62a 225a 287
Expected Count 72.7 214.3 287.0
% within Comorbidities 21.6% 78.4% 100.0%
% within Graduation Status 19.5% 24.0% 22.9%
% of Total 4.9% 17.9% 22.9%
Standardized Residual -1.3 0.7
Count 86a 262a 348
Expected Count 88.2 259.8 348.0
% within Comorbidities 24.7% 75.3% 100.0%
% within Graduation Status 27.0% 28.0% 27.7%
% of Total 6.9% 20.9% 27.7%
Standardized Residual -0.2 0.1
Count 318 937 1255
Expected Count 318.0 937.0 1255.0
% within Comorbidities 25.3% 74.7% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.3% 74.7% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.























Pearson Chi-Square 8.607a 3 0.035 0.035
Likelihood Ratio 8.513 3 0.037 0.037
Fisher's Exact Test 8.414 0.038
Linear-by-Linear Association 3.578b 1 0.059 0.062 0.031 0.004
N of Valid Cases 1255
b. The standardized statistic is 1.891.
Chi-Square Tests




Appendix H: Comparison of Graduation Status and Referral Indication 
Results 
 
N Percent N Percent N Percent
Referral Indication * Graduation 
Status












Pearson Chi-Square 6.865a 9 0.651 .b
Likelihood Ratio 6.867 9 0.651 .b
Fisher's Exact Test .b .b
Linear-by-Linear Association .201c 1 0.654 0.660 0.333 0.008
N of Valid Cases 1263
b. Cannot be computed because there is insufficient memory.
c. The standardized statistic is .448.
Chi-Square Tests








Count 70a 201a 271
Expected Count 68.9 202.1 271.0
% within Referral Indication 25.8% 74.2% 100.0%
% within Graduation Status 21.8% 21.3% 21.5%
% of Total 5.5% 15.9% 21.5%
Standardized Residual 0.1 -0.1
Count 89a 222a 311
Expected Count 79.0 232.0 311.0
% within Referral Indication 28.6% 71.4% 100.0%
% within Graduation Status 27.7% 23.6% 24.6%
% of Total 7.0% 17.6% 24.6%
Standardized Residual 1.1 -0.7
Count 38a 147a 185
Expected Count 47.0 138.0 185.0
% within Referral Indication 20.5% 79.5% 100.0%
% within Graduation Status 11.8% 15.6% 14.6%
% of Total 3.0% 11.6% 14.6%
Standardized Residual -1.3 0.8
Count 50a 157a 207
Expected Count 52.6 154.4 207.0
% within Referral Indication 24.2% 75.8% 100.0%
% within Graduation Status 15.6% 16.7% 16.4%
% of Total 4.0% 12.4% 16.4%
Standardized Residual -0.4 0.2
Count 1a 4a 5
Expected Count 1.3 3.7 5.0
% within Referral Indication 20.0% 80.0% 100.0%
% within Graduation Status 0.3% 0.4% 0.4%
% of Total 0.1% 0.3% 0.4%
Standardized Residual -0.2 0.1
Count 8a 18a 26
Expected Count 6.6 19.4 26.0
% within Referral Indication 30.8% 69.2% 100.0%
% within Graduation Status 2.5% 1.9% 2.1%
% of Total 0.6% 1.4% 2.1%
Standardized Residual 0.5 -0.3
Count 8a 15a 23
Expected Count 5.8 17.2 23.0
% within Referral Indication 34.8% 65.2% 100.0%
% within Graduation Status 2.5% 1.6% 1.8%
% of Total 0.6% 1.2% 1.8%
Standardized Residual 0.9 -0.5
Count 14a 36a 50
Expected Count 12.7 37.3 50.0
% within Referral Indication 28.0% 72.0% 100.0%
% within Graduation Status 4.4% 3.8% 4.0%
% of Total 1.1% 2.9% 4.0%
Standardized Residual 0.4 -0.2
Count 35a 122a 157
Expected Count 39.9 117.1 157.0
% within Referral Indication 22.3% 77.7% 100.0%
% within Graduation Status 10.9% 13.0% 12.4%
% of Total 2.8% 9.7% 12.4%
Standardized Residual -0.8 0.5
Count 8a 20a 28
Expected Count 7.1 20.9 28.0
% within Referral Indication 28.6% 71.4% 100.0%
% within Graduation Status 2.5% 2.1% 2.2%
% of Total 0.6% 1.6% 2.2%
Standardized Residual 0.3 -0.2
Count 321 942 1263
Expected Count 321.0 942.0 1263.0
% within Referral Indication 25.4% 74.6% 100.0%
% within Graduation Status 100.0% 100.0% 100.0%
% of Total 25.4% 74.6% 100.0%
Total
Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.






















Lower Bound Upper Bound
Active 574 56.6498 10.18199 0.42499 55.8151 57.4846 21.00 91.00
Retired 510 71.0118 8.36659 0.37048 70.2839 71.7396 47.00 95.00
Unemployed 40 56.5500 7.74580 1.22472 54.0728 59.0272 40.00 79.00
Medically Disabled 84 53.7738 9.36071 1.02134 51.7424 55.8052 21.00 72.00
Unknown 57 62.4561 11.34849 1.50314 59.4450 65.4673 37.00 87.00
Total 1265 62.5075 11.80894 0.33202 61.8561 63.1589 21.00 95.00
95% Confidence Interval for Mean
Minimum MaximumN Mean Std. Deviation Std. Error
Descriptives
Levene Statistic df1 df2 Sig.
Based on Mean 4.315 4 1260 0.002
Based on Median 4.156 4 1260 0.002
Based on Median and with 
adjusted df
4.156 4 1198.310 0.002
Based on trimmed mean 4.228 4 1260 0.002
Age
Test of Homogeneity of Variances
Age
Statistica df1 df2 Sig.
Welch 195.932 4 153.978 0.000
a. Asymptotically F distributed.







Lower Bound Upper Bound
Retired -14.36194* 0.57336 0.000 -15.9282 -12.7957
Unemployed 0.09983 1.54081 1.000 -4.1093 4.3089
Medically Disabled 2.87602 1.10070 0.069 -0.1308 5.8828
Unknown -5.80631* 1.30849 0.000 -9.3808 -2.2319
Active 14.36194* 0.57336 0.000 12.7957 15.9282
Unemployed 14.46176* 1.54710 0.000 10.2355 18.6880
Medically Disabled 17.23796* 1.10948 0.000 14.2072 20.2688
Unknown 8.55562* 1.31589 0.000 4.9610 12.1503
Active -0.09983 1.54081 1.000 -4.3089 4.1093
Retired -14.46176* 1.54710 0.000 -18.6880 -10.2355
Medically Disabled 2.77619 1.81006 0.541 -2.1684 7.7208
Unknown -5.90614* 1.94343 0.020 -11.2151 -0.5972
Active -2.87602 1.10070 0.069 -5.8828 0.1308
Retired -17.23796* 1.10948 0.000 -20.2688 -14.2072
Unemployed -2.77619 1.81006 0.541 -7.7208 2.1684
Unknown -8.68233* 1.61690 0.000 -13.0993 -4.2654
Active 5.80631* 1.30849 0.000 2.2319 9.3808
Retired -8.55562* 1.31589 0.000 -12.1503 -4.9610
Unemployed 5.90614* 1.94343 0.020 0.5972 11.2151
Medically Disabled 8.68233* 1.61690 0.000 4.2654 13.0993
Retired -14.36194* 0.56380 0.000 -15.9025 -12.8214
Unemployed 0.09983 1.29636 1.000 -3.5716 3.7713
Medically Disabled 2.87602 1.10623 0.077 -0.1905 5.9425
Unknown -5.80631* 1.56207 0.004 -10.1887 -1.4239
Active 14.36194* 0.56380 0.000 12.8214 15.9025
Unemployed 14.46176* 1.27953 0.000 10.8307 18.0929
Medically Disabled 17.23796* 1.08646 0.000 14.2227 20.2532
Unknown 8.55562* 1.54813 0.000 4.2079 12.9033
Active -0.09983 1.29636 1.000 -3.7713 3.5716
Retired -14.46176* 1.27953 0.000 -18.0929 -10.8307
Medically Disabled 2.77619 1.59470 0.414 -1.6619 7.2143
Unknown -5.90614* 1.93891 0.024 -11.2980 -0.5142
Active -2.87602 1.10623 0.077 -5.9425 0.1905
Retired -17.23796* 1.08646 0.000 -20.2532 -14.2227
Unemployed -2.77619 1.59470 0.414 -7.2143 1.6619
Unknown -8.68233* 1.81730 0.000 -13.7270 -3.6376
Active 5.80631* 1.56207 0.004 1.4239 10.1887
Retired -8.55562* 1.54813 0.000 -12.9033 -4.2079
Unemployed 5.90614* 1.93891 0.024 0.5142 11.2980
Medically Disabled 8.68233* 1.81730 0.000 3.6376 13.7270

























Lower Bound Upper Bound
>2 Comorbidities 399 64.2757 10.76212 0.53878 63.2165 65.3349 21.00 95.00
No Comorbidity 221 59.4299 12.32074 0.82878 57.7965 61.0632 23.00 91.00
1 Comorbidity 287 61.8293 12.51805 0.73892 60.3749 63.2837 23.00 92.00
2 Comorbidities 350 63.0000 11.64691 0.62255 61.7756 64.2244 21.00 92.00
Total 1257 62.5099 11.81095 0.33313 61.8564 63.1635 21.00 95.00
Descriptives
N Mean Std. Deviation Std. Error
95% Confidence Interval for Mean
Minimum Maximum
Levene Statistic df1 df2 Sig.
Based on Mean 2.403 3 1253 0.066
Based on Median 2.398 3 1253 0.067
Based on Median and with 
adjusted df
2.398 3 1236.336 0.067
Based on trimmed mean 2.384 3 1253 0.068
Test of Homogeneity of Variances
Age
Age
Sum of Squares df Mean Square F Sig.
Between Groups 3557.654 3 1185.885 8.657 0.000




Lower Bound Upper Bound
No Comorbidity 4.84582* 0.98144 0.000 2.3211 7.3706
1 Comorbidity 2.44642* 0.90591 0.035 0.1160 4.7769
2 Comorbidities 1.27569 0.85718 0.445 -0.9294 3.4808
>2 Comorbidities -4.84582* 0.98144 0.000 -7.3706 -2.3211
1 Comorbidity -2.39940 1.04748 0.101 -5.0940 0.2952
2 Comorbidities -3.57014* 1.00563 0.002 -6.1571 -0.9832
>2 Comorbidities -2.44642* 0.90591 0.035 -4.7769 -0.1160
No Comorbidity 2.39940 1.04748 0.101 -0.2952 5.0940
2 Comorbidities -1.17073 0.93206 0.591 -3.5684 1.2270
>2 Comorbidities -1.27569 0.85718 0.445 -3.4808 0.9294
No Comorbidity 3.57014* 1.00563 0.002 0.9832 6.1571
1 Comorbidity 1.17073 0.93206 0.591 -1.2270 3.5684
No Comorbidity 4.84582* 0.98852 0.000 2.2957 7.3959
1 Comorbidity 2.44642* 0.91448 0.038 0.0900 4.8029
2 Comorbidities 1.27569 0.82332 0.409 -0.8444 3.3958
>2 Comorbidities -4.84582* 0.98852 0.000 -7.3959 -2.2957
1 Comorbidity -2.39940 1.11035 0.136 -5.2620 0.4632
2 Comorbidities -3.57014* 1.03656 0.003 -6.2431 -0.8972
>2 Comorbidities -2.44642* 0.91448 0.038 -4.8029 -0.0900
No Comorbidity 2.39940 1.11035 0.136 -0.4632 5.2620
2 Comorbidities -1.17073 0.96621 0.620 -3.6600 1.3186
>2 Comorbidities -1.27569 0.82332 0.409 -3.3958 0.8444
No Comorbidity 3.57014* 1.03656 0.003 0.8972 6.2431
1 Comorbidity 1.17073 0.96621 0.620 -1.3186 3.6600

















Appendix K: Logistic Regression Model for Graduation Status Results 
Case Processing Summary 
Unweighted Casesa N Percent 
Selected Cases Included in Analysis 1253 99.1 
Missing Cases 12 0.9 
Total 1265 100.0 
Unselected Cases 0 0.0 
Total 1265 100.0 














(1) (2) (3) (4)
Active 569 0.000 0.000 0.000 0.000
Retired 508 1.000 0.000 0.000 0.000
Unemployed 40 0.000 1.000 0.000 0.000
Medically Disabled 83 0.000 0.000 1.000 0.000
Unknown 53 0.000 0.000 0.000 1.000
>2 Comorbidities 398 0.000 0.000 0.000
No Comorbidity 220 1.000 0.000 0.000
1 Comorbidity 287 0.000 1.000 0.000
2 Comorbidities 348 0.000 0.000 1.000
University 630 0.000 0.000 0.000
High School or Less 187 1.000 0.000 0.000
College/Post-Secondary 375 0.000 1.000 0.000
Unknown 61 0.000 0.000 1.000
Caucasian 1032 0.000 0.000
African American 86 1.000 0.000












Step 63.022 14 0.000
Block 63.022 14 0.000
Model 63.022 14 0.000
Step 1














-2 Log likelihood Cox & Snell R Square
Nagelkerke R 
Square
1 1354.370a 0.049 0.072
Model Summary
Step
a. Estimation terminated at iteration number 4 because parameter estimates changed by less than .001.
Not Graduated Graduated
Not Graduated 17 300 5.4
Graduated 12 924 98.7
75.1
Step 1 Graduation Status
Overall Percentage








Age 0.016 0.007 4.878 1 0.027 1.016 1.002 1.030
Sex(1) 0.128 0.150 0.725 1 0.395 1.136 0.847 1.525
Occupation Status 7.634 4 0.106
Occupation Status(1) 0.166 0.184 0.816 1 0.366 1.181 0.823 1.693
Occupation Status(2) 0.192 0.380 0.254 1 0.614 1.211 0.575 2.553
Occupation Status(3) -0.539 0.259 4.333 1 0.037 0.583 0.351 0.969
Occupation Status(4) -0.303 0.333 0.827 1 0.363 0.739 0.384 1.419
Comorbidities 7.165 3 0.067
Comorbidities(1) 0.407 0.207 3.874 1 0.049 1.502 1.002 2.253
Comorbidities(2) 0.440 0.187 5.526 1 0.019 1.553 1.076 2.241
Comorbidities(3) 0.287 0.172 2.788 1 0.095 1.332 0.951 1.866
Education 25.089 3 0.000
Education(1) -0.832 0.195 18.279 1 0.000 0.435 0.297 0.637
Education(2) -0.658 0.159 17.223 1 0.000 0.518 0.380 0.707
Education(3) -0.446 0.330 1.830 1 0.176 0.640 0.335 1.222
Race 1.094 2 0.579
Race(1) 0.277 0.269 1.063 1 0.303 1.319 0.779 2.234
Race(2) -0.018 0.219 0.007 1 0.935 0.982 0.640 1.508




a. Variable(s) entered on step 1: Age, Sex, Occupation Status, Comorbidities, Education, Race.
B S.E. Wald df
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